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Abstract 
 
 
This work aimed at the development of a (bio)polymeric  monolithic support 
for biopharmaceuticals purification and/or capture. For that, it was assured that 
functional groups on its surface were ready to be involved in a plethora of chemical 
reactions for incorporation of the desired and most suitable ligand. Using cryogelation 
as preparation method a screening on multiple combinations of materials was 
performed in order to create a potentially efficient support with the minimal footprint, 
i.e. a monolithic support with reasonable mechanical properties, highly permeable, 
biocompatible, ready to use, with gravitational performance and minimal unspecific 
interactions towards the target molecules, but also biodegradable and produced from 
renewable materials. For the pre-selection all monoliths were characterized physico-
chemically and morphologically; one agarose-based and two chitosan-based monoliths 
were then subjected to further characterizations before and after their modification 
with magnetic nanoparticles. These three specimens were finally tested towards 
adenovirus and the recovery reached 84% for the chitosan-GMA plain monolith 
prepared at -80°C.  
Monoliths based on chitosan and PVA were prepared in the presence and 
absence of magnetic particles, and tested for the isolation of GFP directly from crude 
cellular extracts. The affinity ligand A4C7 previously selected for GFP purification was 
synthesized on the monolith. The results indicated that the solid-phase synthesis of the 
ligand directly onto the monolith might require optimization and that the large pores 
of the monoliths are unsuitable for the purification of small proteins, such as GFP. 
  
 
KEYWORDS: Biopolymers; Cryogelation; Magnetic Nanoparticles; Polymeric 
Monolith; Purification 
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Resumo 
 
 
Este trabalho teve como objetivo desenvolver um suporte monolítico 
(bio)polimérico para purificação/captura de biofármacos. Para isso, a presença de 
grupos funcionais na superfície, prontos para intervir em múltiplas reacções químicas 
como a incorporação do ligando desejado, foi assegurada. Usando a criogelação como 
método de preparação, foi realizada uma selecção preliminar a partir de múltiplas 
combinações de materiais, para assim se obter um suporte monolítico potencialmente 
eficiente com impacto ambiental mínimo, ou seja, um suporte com propriedades 
mecânicas razoáveis, altamente permeável, biocompatível, com desempenho 
gravitacional e interacções inespecíficas mínimas entre o alvo e o suporte, mas que seja 
também biodegradável e produzido a partir de materiais renováveis. Para a pré-
seleção todos os monolitos foram caracterizados físico-química e morfologicamente. 
Em seguida, os três monolitos pré-selecionados - um monolito tendo como biopolímero 
base a agarose e dois monolitos tendo como biopolímero base o quitosano - foram 
submetidos a outras caracterizações, antes e depois da sua modificação com 
nanopartículas magnéticas. Por fim, as três espécies mencionadas, modificadas ou não 
com nanopartículas magnéticas, foram testadas com uma solução previamente 
purificada de adenovírus. O valor máximo de recuperação foi de 84% para o monólito 
quitosano-GMA nativo preparado a -80°C.  
Prepararam-se monolitos de quitosano e PVA na presença e ausência de 
nanopartículas magnéticas. Estes foram testados na isolação de GFP directamente a 
partir de estratos celulares brutos. O ligando de afinidade A4C7, previamente 
seleccionado para a purificação de GFP, foi sintetizado na superfície do monólito. Os 
resultados indicaram que a síntese em fase sólida do ligando directamente no monolito 
requer optimizações e que os grandes poros dos monolitos preparados não são 
adequados para a purificação de pequenas proteínas como a GFP. 
 
 
PALAVRAS-CHAVE: Biopolímeros; Criogelação; Monolito Polimérico; 
Nanopartículas Magnéticas; Purificação 
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1.1. Monoliths in Bioseparation 
 
 
Adsorption chromatography can be performed using distinct solid phase 
media, namely porous beads, membranes, and monoliths (Figure 1.1.). Porous particle-
based supports are currently the most widely employed stationary phases for 
purification of biomolecules, particularly proteins1. However, due to present research 
and market evolution towards large biomolecules (virus, DNA, intact cells, complex 
proteins) in (bio)pharmaceutical  industry, and particle-based media inadequacy to 
purify this types of molecules, monoliths arise as a promising  alternative1–3. 
 
 
 
 
Figure 1.1.- Classification of chromatography stationary phases according to their 
morphology4,5. Micropores size correspond to values below 2 nm, mesopores size to values 
between 2-50 nm, macropores size to values between 50-5x105 nm, and super-macropores to 
values between 5x103-1x105 nm6–9. 
 
 
Monolith is defined as a continuous and porous stationary phase moulded as a 
column and inserted in a chromatography housing2,5. Their “format can be compared to a 
single large particle”10, and include “compressed hydrophilic gels, macroporous polymer discs, 
columns, tubes and silica rods”10. 
 
Beyond the possibility of being prepared through several procedures and 
distinct chemistries, monoliths can also be tailored to present differences at 
microstructural level (e.g. pore size and geometry)11,12. However, they are all 
characterized by high porosity and pore interconnection, leading to the formation of a 
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network of channels5. This single structure allows mobile phase to flow through these 
channels by convection, minimizing mass transport resistance (low backpressure) and 
increasing separation speed, independently of molecular size or diffusion coefficient5. 
These flow-through pores characterized by convective transportation of mass are thus 
responsible for the flow independent chromatographic properties of monoliths, such as 
dynamic binding capacity and resolution, and consequently for the efficient high speed 
assays13,14. In fact, monoliths exhibit plate efficiencies that compete with finest bead-
packings14. 
This constitutes a totally different picture compared to diffusion, the 
representative driving force of mass transfer between solid surface and bulk liquid 
phases on porous packed-beads separation media, a slow phenomenon dependent on 
molecular weight5,2. This phenomenon takes place due to the adsorption surface 
shallow dead-end pores with 10–100 nm large, where neither convective transport can 
be achieved nor big molecules like virus, DNA and cells can have access5,15. The mass 
transport dependence on molecular weight of analytes comprises the speed of the 
assays and can only be overcome with resolution and binding capacity commitment. 
The independence of dynamic binding capacity and resolution from flow-rate can be 
achieved with non-porous micrometerized small beads (<5µm) made of silica or 
synthetic polymers. However due to its low porosity compared to monoliths, only 
short column lengths can be used to avert high backpressures and achieve attractive 
assay speeds13. Moreover in particulate-bead packings there are preferential paths for 
the solution – interparticle void volumes (~40% of total bed volume1) – where flow 
vortices (eddies) are created due to differential friction between particle surfaces and 
inter-particle void areas. This eddies origin turbulent mixing that reduce resolution, 
broaden peaks, and may cause shear forces that can harm sensitive/unstable molecules, 
lowering yields. Perfusive particles, with channels transecting them, allow a little 
increase on convective mass transport together with an increment on bio-nanoparticles 
accessible area, however this type of beads are not free from the undesired void 
volumes, where fluid flows preferentially and eddies occur1. 
Conversely to packed beads, and equally to monoliths, membranes are 
designed particularly to take the maximum advantage of convective transport. In fact, 
a membrane can even be almost equalized to a monolith, once it is cast as a single 
continuous unit provided with large channels rather than pores. Nevertheless, their 
exceedingly flat bed height, their usually smaller channels width (generally not 
surpassing 1µm1 against ~100µm for monolithic cryogels9,16), together with the different 
physical arrangements in which they are applied (e.g. stacked membranes, pleated 
cartridge) make them distinct from monoliths in terms of operating features17,1. In fact 
all these differences together render membrane arrangement less effective compared to 
the monolith one. Inside membrane housings there is an uncontrolled and uneven 
distribution of flow-rates (inlet side of membrane), together with turbulent mixing 
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between membrane layers forming the dead or void volumes; all this is due to the 
discontinuity of channels, consequence of the discontinuous character of the whole 
format (discontinuous pore distribution) and the characteristic inlet arrangement 
itself5. As the turbulent mixing occurring in these void volumes can be compared to 
eddy dispersion in porous bead supports1, the threat of shear forces presence as 
consequence of eddies formation is a possibility, and so it is product integrity 
commitment. The flow aberrations located on the outlet side of the membrane generate 
dispersion decreasing process performance5. So the flow uneven distributions and 
undesired behaviours are thus responsible for a slight decrease on capture efficiency 
and strong reduction on elution efficiency (unwell resolved peaks).  
In turn, monoliths not only exhibit a binding capacity three times wider than 
membranes14 but also lack the dead volumes. In fact the laminar flow through all 
monolith avoid eddies, decrease shear, and guarantees immediate response to 
variations in buffer composition, maximizing elution kinetics and contributing to 
sharper, better resolved and more concentrated elution peaks, and high functional 
recoveries. They offer “the selectivity of particulate resins and the throughput of membrane 
absorbers”18, suggesting that monoliths should be more efficient, especially when it 
comes to larger biomolecules purification14,2. 
Table 1.1. presents a comparison between the three main chromatographic 
media available. 
Monoliths that can be prepared in multiple ways and also find diverse 
applications, are usually easy to prepare in various sizes and shapes from different 
materials and through different methods. Monoliths surface can then be or not 
chemically modified with multiple molecules and applied in the  capture/purification 
of large biomolecules, as they present fast performance at low pressures and room 
temperature, and a high productivity due to their flow-independent properties2,13.  
The retention of target molecule can be performed through selective 
electrostatic, hydrophobic, affinity or pseudo-affinity interactions; and nature of the 
matrix has potential to vary widely; however either commercially available monoliths 
or lab developed ones are mostly composed by silica, acrylamide or methacrylates6,3,19.  
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Table 1.1.- Benefits and limitations of each chromatographic media type used in 
bioseparation. The present comparison of generalized structures of porous beads, stacked 
membranes, and monoliths is not drawn to scale. Black arrows show the bulk convective flow, 
and shaded orange areas the diffusion regions. Green curling arrows show turbulent flow 
(eddies) with consequent counter-current between laminar flow and eddy flow (creating shear). 
In case of beads media green arrows represent inter-particles eddies. Table based on 20,21,5,2. 
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 High product purity (SM); 
 Consistency and  safety;  
 Industrial scale well known; 
 High adsorption and elution 
efficiency (SM); 
 High surface area and high 
binding capacity (SM); 
 Multiple column chemistries and 
HPLC column dimensions are 
commercially available; 
 Validated applications/assays. 
 Low pressure drop; 
 high flow rates; 
 Small footprint; 
 Inexpensive; 
 Disposable; 
 Moderate resolution; 
 High hydraulic permeability; 
 Rapid mass transfer 
(convection), allowing high 
flow rates with high 
productivity and major 
decrease in separation times.  
 
 High porosity; 
 Large interconnected channels with rapid mass 
transfer (convection), allowing high flow rates 
with major increase crease in separation  times; 
 High productivity; 
 No void volumes and laminar flow, so no eddies 
are formed, neither shear; 
 High purity products; 
 Ease of preparation and processing in various 
volumes and shapes (PM); 
 Flexible surface chemistry for ligand 
attachment, due to plethora possible usable 
materials; 
 High hydraulic permeability; 
 Inexpensive; 
 Moderate-high resolution; 
 Low-moderate pressure drop; 
 High binding capacity (BM); 
 Mechanically robust; 
Li
m
it
a
ti
o
n
s 
 High pressure drop; 
 Weak mechanical properties;  
 Eddy dispersion and shear  forces 
due to voids compromising 
productivity; 
 Extensive footprint; 
 Moderately expensive; 
 Low binding capacity (BM); 
 Peak broadening, resolution and  
recovery worsens with flow rate 
(BM); 
 Low mass transfer (diffusion) 
with consequent low flow-rates  
 High backpressure; 
 Extra machinery required for 
sample solution to cross media; 
 Air incursion into column 
destroys bed integrity. 
 Low binding capacity; 
 Limited available surface 
area; 
 Shear forces due to eddies; 
can compromise productivity 
 Flow aberrations compromise 
performance; 
 Fouling; 
 Broad peaks due to eddies  
(desirable in situations where 
neither high purity nor high 
eluted product concentration 
is required); 
 Accumulated bubbles difficult 
to displace without breaking 
system sterility. 
 Scale-up difficult; 
 Low specific surface area per unit volume, and 
so low binding capacity for SM and medium 
large proteins as monoclonal antibodies; 
 Extensive footprint; 
 Low efficiency (SM) and HPLC column to 
column reproducibility; 
 Limited column chemistries and dimensions 
commercially accessible; 
 Constrained use in routine analysis due to few 
commercial suppliers available. 
 
 
 
 
 
 
 
 
PM: Polymeric Monolith; BM: Big Molecules; SM: Small Molecule 
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Currently, this new category of porous media has been extensively applied in 
analytical chemistry, mainly in separation science areas. Through liquid 
chromatography, namely high performance liquid chromatography (HPLC) and 
capillary electrochromatography (CEC)22, monolith stationary phase has been used to 
capture, purify, enrich and analyse diverse bio-nanoparticles, from plasmidic and 
genomic nucleic acids to organelles, inclusion bodies, virus and other macromolecular 
assemblies2,23. The specific interactions between the target macro-biomolecule and the 
adsorptive matrix allow their isolation from related small molecules24. Table 1.2. shows 
some applications of monoliths as sorbents for isolation of macro-biomolecules. 
 
Table 1.2.- Examples of the application of monoliths in bioseparation. 
Monolith 
Material 
Mode Ligand Application/Target(s) 
Pore 
Size 
(µm) 
Surface 
Area 
(m2/g) 
Capacity 
Recovery 
(%) 
Purity Ref 
GMA-EDMA CEC Acetic Acid 
Purification and 
simultaneous renaturation 
of rhIFN-γ 
0.4-2.0 
(>80%) 
n.a.a n.a. n.a. 93% 25 
(Hybrid 
silica) TEOS-
AEAPMDMS 
AEC 
Amine 
groups 
Extraction of genomic 
DNA from blood 
≤6.0 n.a. 
9.3 
ng/cm 
52.1 n.a. 26 
Chitosan-
PVA cryogel 
Affinity 
(Artificial 
protein A) 
ligand 22/8 
Capture of pure IgG, and 
direct capture and 
recovery of mAb from a 
non-clarified homogenate 
~45 2.3 
150 
mg/g 
90, 48 98% 27 
CIM AEC Q 
Isolation of bacterial 
ribosomes from crude cell 
lysates 
0.6-5.0 ~40 n.a. n.a. 
< sucrose 
gradient 
centrifugati
on 
28 
Concentration and 
purification of rubella 
virus from a complex 
biological suspension 
0.6-5.0 ~40 n.a. ~100 High 29 
Aam-AGE-
MBA 
IMAC IDA-Cu2+ 
Direct capture of enzyme 
(His)6-LDH from non-
clarified crude cell 
homogenate 
0.01-
100 
n.a. 
0.13 
mg/ml 
70-90 
Need to be 
improved 
9 
Chromatography of E. coli 
cells 
0.01-
100 
n.a. n.a. 80 Reasonable 30 
Aam-
DMAEMA-
MBAAm 
AEC DEAE 
Chromatography of E. coli 
cells 
0.01-
100 
n.a. n.a 70–80 
Need to be 
improved 
30 
LMA-EDMA-
VPBA 
CEC 
and 
HIC 
Boronic acid 
and C12 
chain 
Analysis and identification 
of cis-diol 
biomolecules/TRF 
5x10-3–
50x10-3 
43.5-
54.8 
n.a. n.a. 
Need to be 
improved 
31 
Aam-
MBAAm-
GMA 
Affinity Streptavidin 
Single-step capture of 
chemically biotinylated 
MoMuLV 
0.01-
100 
n.a. 
2x105 
cfu/mL 
<8 High 32,9 
 
PHEMAH 
cryogel
 
Pseudo
Affinity 
MAH purification of pDNA 10–100 n.a. 
13,350 
µg/g 
90 Reasonable 33 
 
 
 
 
CEC: Cation-exchange chromatography; AEC: Anion-exchange chromatography; IMAC: Immobilized methal affinity chromatography; 
HIC: Hydrophobic interaction chromatography; rhIFN-γ: Recombinant human interferon gamma (growth factor); TRF: Transferrin; 
MAH: N-methacryloyl-(l)-histidine methyl ester; PHEMAH: Poly(hydroxyethyl methacrylate-Nmethacryloyl-(L)-histidine methyl ester). 
MoMuLV: Moloney Leukemia virus; cfu: colony forming units 
a) Data no available on the literature as far as we are concerned. 
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Besides their wide applicability in bioseparation (liquid chromatography, 
capillary separations, capillary electrochromatography (CEC), thin-layer 
chromatography, gas chromatography)9,29,32,27,25,34,22 as adsorbent matrices, monoliths 
have also found usefulness in sample pre-treatment21,23, catalysis35,36 (mainly towards 
micro-scale protein mapping or proteomic analysis36,37), solid phase and combinatorial 
chemistry38,39,  scavenging40, as static mixers41, drug delivery, in vitro cell cultivation, 
and tissue engineering42,43.  
 
 
1.1.1. Methods to Produce Monoliths 
 
 
Despite the possibility of monoliths to be miniaturized into capillaries, 
microfluidic devices or microarrays, they are usually prepared on an analytical scale: in 
a conventional large column/rod, tube or disk format, in a multi-well plates format for 
screenings assays44,2, in a thin-layer format for planar chromatography34,2, or with a tip 
geometry45,2.  
 Monoliths can be divided into organic polymer monoliths, inorganic silica 
monoliths and hybrid organic-silica monoliths. Inorganic silica monoliths can be 
fabricated by (i) fusion of porous silica beads through thermal sintering, (ii) 
cementing/immobilizing silica beads in a packed bed by cross-linking/entrapping them 
through sol-gel process, or (iii) polymerization of sol-gel precursors (silicon alkoxide). 
The latter, a waste-free method, is the most commonly used46. 
Recently a review on what authors called ‘exotic monoliths’, shows that beyond 
the famous silica gel-based monoliths inorganic monoliths can be prepared from both a 
‘pure’ metal or a metal-oxide, and be applied in separation science47. 
In turn organic polymer monoliths can be prepared from i) solely a polymer, ii) 
a blend of polymers, iii) a polymerization of monomers in presence or not of one or 
more polymers, or (iv) co-polymerization of monomers in presence or not of one or 
more polymers; using  a variety of possible methods12,48,49 (Table 1.3.). Generally they 
are produced by in situ polymerization of a mixture containing monomer(s) 
(commonly acrylamides, methacrylates, or styrene50,6), crosslinker, porogenic solvent(s) 
and an initiator, using a simple moulding procedure executed inside a mould such as a 
chromatographic column, capillary or micro-channel (see figure 2 on Nordborg et al. 
work51). The most employed method is the free radical polymerization, more precisely 
the thermally and UV irradiation photo-initiated approaches48. Other approaches have 
been explored, such as microwave or γ radiation initiated polymerizations51,12,52. 
Recently 1-vinyl-3-octylimidazolium (ViOcIm+) ionic liquid-based monoliths were 
prepared via thermal free radical copolymerization and  used to separate a mixture of 
standard proteins (BSA, quine myoglobin, lysozyme and cytochrome c)53.  
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Table 1.3.- Methods for preparation of organic monoliths to be applied in separation 
science12,54,48. 
Preparation 
Method 
Materials 
Initiator/ 
Porogen/ 
Other 
Pore 
Size 
(µm) 
Application Obs. Ref 
Thermally 
initiated free 
radical 
polymerization 
(TIFRP) 
PA:PDA 
(50:50 
%w/w) 
AIBN / 
2-propanol, 
THF 
0.22 
Separation of 
proteins and oligo-
deoxynucleotides 
 1st method used for preparation of rigid 
polymer-based monoliths; 
 Very simple; 
 Process origin can be traced down to 
techniques generally applied in 
preparation of porous beads by 
suspension polymerization; 
 High reproducibility; 
 Assembled by irregular micro-globules 
forming aggregated clusters, leading to 
some limitations (e.g.  permeability) (all 
FRP). 
54,55,
12,56 
Photo-initiated 
free radical 
polymerization 
(UV rays) 
GMA:  
EGDMA: 
BMA 
(51:40:5 
%v/v) 
AIBN / 
1-dodecanol, 
cyclohexanol 
0.5-3 
High throughput 
sample clean-up 
throughput. 
Roscovitine and 
lidocaine in plasma 
samples used as 
model substances. 
 Faster than TIFRP; 
 Can lead to columns with lower 
backpressure, and better 
chromatographic performance than 
TIFRP (comparing columns of same pore 
size); 
 Reaction can be stopped when 
irradiation source is removed and 
column is flushed; 
 Limited by use of UV transparent molds 
with a small size in one dimension and 
UV transparent monomers, exclusion of 
aromatic monomers, and wavelength of 
maximum absorbance of initiator; 
57,54,
12,58,
59 
Photo-initiated 
free radical 
polymerization 
(visible light) 
St:DVB 
(50:50  
%v/v) 
mixture of CQ, 
EDAB, MPPB / 
ACN, 
1-propanol, 
1-decanol 
n.a.a 
Separation of 
mixture of standard 
proteins: 
ribonuclease 
A, cytochrome c, 
myoglobin and 
ovalbumin 
 Performed at room temperature, allows 
less common porogens usage, including 
those with low boiling point. 
58 
Radiation 
initiated free 
radical 
polymerization 
(ƴ-rays) 
DEGDMA: 
GMA 
No initiator / t-
butanol or 
methanol or 
ethanol or 
propanol or 
acetone or THF 
or 
ethylpropionat
e 
~3 
Diagnostics and 
purification 
 Faster than TIFRP; 
 Greater penetration depth of radiation 
than UV-initiated polymerization, 
allowing preparation of any volume 
monoliths; 
 No initiator needed; 
 Pore volume and pore size distribution 
tuning in a broad range through process 
variables as irradiation dose and dose 
rate, non-available in other 
polymerization processes. 
60,61 
Radiation 
initiated free 
radical 
polymerization 
(microwaves) 
St:DVB: 
MAA 
(33.3: 
33.3:33.3  
%v/v) 
AIBN / toluene, 
isooctane 
0.28 
-8.88 
pCEC, CEC, LPLC of 
neutral compounds 
(thiourea, 
benzene, toluene, 
ethyl benzene, 
biphenyl, 
naphthalene) 
 Polimerization time shortened from 24h 
(TIFRP) to 15min; 
 Lower expense than TIFRP and UV-ligth 
initiated FRP. 
62 
(Continued) 
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Table 1.3. (Continued) 
Preparation 
Method 
Materials 
Initiator/ 
Porogen/ 
Other 
Pore 
Size 
(µm) 
Application Obs. Ref 
Radiation 
initiated free 
radical 
polymerization 
(electron 
beam) 
EMA: 
TMPTA 
(50:50  
%w/w) 
No initiator / 2-
propanol, 1-
dodecanol 
0.08-
0.11 
Separation of 
proteins: lysozyme, 
ribonuclease, 
insulin, cytochrome 
c, andalbumin; 
heterogeneous 
catalysis 
 No initiator needed; 
 Successful column scale up reported; 
 Fastest separation with sufficient peak 
resolution, in comparison to ROMP 
prepared monoliths. 
52 
Polymerization 
by high 
internal phase 
emulsions 
(polyHIPE) 
GMA: 
EGDMA 
(77:23  
%w/w) 
Potassium 
persulfate / 
Emulsified 
water droplets 
/ calcium 
chloride 
hexahydrate (el
ectrolyte) and 
Synperonic PEL 
121 (surfactant) 
~0.1 
(holes 
size 
1 -10) 
Separation of 
standard protein 
mixture of 
myoglobin, 
conalbumine and 
trypsin inhibitor 
 Good separation in a very short time, 
comparable to separation achieved by 
commercial methacrylate monoliths 
(FRP); 
 Monoliths characterised by high 
porosity (>70%) and large spherical 
hollows interconnected by ‘‘windows’’; 
 Possible drawback: monoliths present 
low specific surface area, restraining its 
use in separation science. 
63,12,
64 
Cryogelation 
HEMA: 
MAH 
(PHEMAH) 
APS / 
Water crystals / 
TEMED 
(catalyst) 
10–
100 
Purification of 
pDNA 
 Freezing temperature define pore size; 
 Due to large produced pores (1–100µm) 
and high porosity (≤90%), 
hydrodynamic cryogels properties are 
exceptional. 
12,65,
33 
Living 
Polymerization  
Nitroxide 
Mediated 
(SFRP) 
St:DVB 
(50:50  
%w/w) 
Benzoyl 
peroxide / PEG 
400, 1-decanol 
/ 3-carboxy-
PROXYL or 4-
carboxy-
TEMPO 
(promoter) 
≤0.01-
1 
separation of 
mixture of 
myoglobin, 
cytochrome c, and 
lysozyme 
 Slower kinetics characterizing TEMPO-
mediated polymerizations avoids 
significant shifts in pore size 
distribution; 
 TEMPO-capped dormant radicals usable 
for grafting pore surface and tailoring 
its chemistry; 
 Initiator remains on or within the 
material, enabling post-polymerization 
modifications. 
 Least versatile (against ATRP, and RAFT) 
12,66 
Living 
Polymerization 
(TERP) 
MBAAm 
AIBN / PEO 
(phase- 
separator) / 
BTEE 
(promoter) 
0.5 -2 
Aqueous phase 
applications 
(bioseparation, 
support for 
catalysis) 
 A recent strategy lacking preparation of 
columns and chromatographic 
evaluation of their performance; 
 High surface areas attained may ease 
separation of small molecules in 
isocratic mode; 
 High temperatures employed. 
67 
Living 
Polymerization 
(ATRP) 
VC:EDMA 
(50:50  
%v/v) 
CCl4 / dodecyl 
alcohol / FeCl2 
(catalyst) 
0.85 
Separation of: IgG 
from human 
plasma, lysozyme 
from egg white, and 
mixture of papain, 
snailase, IgG. 
 Control over rate of monomer 
combination with growing polymer 
chain (chains similar in length) (all LP); 
 Highly homogeneous crosslinking due 
to isotropic spinodal decomposition 
promotion possibility (ATRP, TERP); 
 Popular in general polymer chemistry, 
but poorly explored in monoliths 
preparation. 
68,12 
Living 
Polymerization 
(RAFT) 
MAA: 
EDMA 
AIBN / Toluene, 
dodecanol / 
DBTTC  (chain 
transfer) 
n.a. 
Extraction of 
clenbuterol from 
biological samples 
 Surface functionalization eased (all LP); 
 Control over polymerization kinetics, 
structure morphology and surface 
functionality (all LP). 
69,70 
(Continued) 
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Table 1.3. (Continued) 
Preparation 
Method 
Materials 
Initiator/ 
Porogen/ 
Other 
Pore 
Size 
(µm) 
Application Obs.  
Living 
Polymerization 
(ROMP) 
NBE: 
DMN-H6 
or COE:CL 
(50:50  
%w/w) 
[RuCl2 
(PCy3)2(CHPh)] 
or 
[RuCl2(Py)2(IMe
sH2)CHPh] / 2-
Propanol, 
toluene 
0.006 
-~0.04 
 
Separation of 
Ribonuclease 
A , carbonic 
Anhydrase, insulin, 
cyctochrome C,  
albumin 
 Restricted range of possible monomers; 
 Noticeable irregularities in the porous 
structure with increasing ratio of pore 
size to the capillary diameter. 
71,12 
Poly-
condensation 
polyglycer
ol-3-
glycidyl 
ether 
BF3·Et2O in 
dioxane / 
Toluene, t-butyl 
methyl ether 
22 
Capture of Gram-
negative bacteria 
 Oxygen insensitive reaction, rendering 
unnecessary the careful de-aeration 
required for FRP; 
 Produces attractive morphological 
structures for separation; 
 Mild reaction conditions and possibility 
of room temperature employment 
avoids pore structure heterogeneities in 
contrast to FRP. 
72 
Thermally 
induced phase 
separation  
Polyamide 
No initiator 
needed / 
Benzyl alcohol 
~0.01-
~0.02 
n.a. 
 Structures produced present uniform 
architecture. Exceptionally simple 
method (thermally controlled 
dissolution and phase segregation 
process) for preparing monoliths with 
attractive chemical, physical and porous 
properties. 
73 
Non-solvent 
induced phase 
separation 
Polycarbo
nate 
No initiator 
needed / 
Cyclohexane 
0.45-
3.2 
Adsorption ofmetal 
ions and 
purification of 
proteins 
 Easy and clean process, so morphology 
tailoring is easy. 
74 
 
 
  
 
 
 
Another attractive method for the preparation of monoliths is cryogelation. This 
versatile technique allows the preparation of elastic and sponge-like structures with a 
broad range of porosities, and gives rise to highly interconnected supermacroporous 
matrices with 100µm sized pores. Moreover its green character does not go 
unnoticed75,12,65,33.  
A 2010 review from Svec12 gathers all different polymerization methods that 
could be used to prepare polymeric monolith structures, so far. However since that 
comprehensive publication, several developments in this area have been made, with 
some breakthrough approaches reported48, namely, the growing incorporation of 
nanostructures into monoliths like nanoparticles of silica, gold, silver, metal oxides, 
hydroxiapatite, and polymers, or carbon nanotubes76. This strategy aims to tailor 
surface characteristics, incorporating nanostructures features into monoliths, what 
increases surface area-to-volume ratio, and consequently offers an extended surface for 
biomolecules adsorption, possibly facilitating mass transfer and improving separation 
THF: Tetrahydrofuran; PA: Phenyl Acrylate; PDA: 1,4-Phenyl Diacrylate; BMA: Butyl Methacrylate; EDMA: Ethylene Glycol Dimethacrylate; 
St: Styrene; DVB: Divinyl Benzene; MAA: Methacrylic Acid; PEO: Poly(ethylene oxide); TEMPO: 2,2,6,6-Tetramethyl-1-piperidyloxy  VC: Vinyl 
Carboxylate; SFRP: Stable Free Radical Polymerization TERP: Organotellurium-mediated living Radical Polymerization; ATRP: Atom Transfer 
Radical Polymerization; NMP: Nitroxide-Mediated Polymerization; RAFT: Reversible Addition-Fragmentation Chain Transfer; ROMP: Ring-
Opening Metathesis Polymerization; polyHIPE: Polymerization by High Internal Phase Emulsion; LP: Living Polymerization; FRP: Free radical 
Polymerization. 
a) Data no available on the literature as far as we are concerned. 
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efficiency76,77. The incorporation of particles can be performed by embedding them into 
the matrix, which includes simply its dispersion (entrapment) or polymerization of 
their dispersions into polymerizing mixture (co-/polymerizing monomers attached by 
functionalized nanoparticles), or by immobilizing them on surface of manufactured 
monoliths through surface coating76,78. To our knowledge, up to now, just a recent 
unpublished work accomplished the embedding of iron oxide MNPs into monoliths to 
be used in analytes separation (IgG), more specifically an external magnetic field aided 
separation79. 
 
Table 1.4.- Benefits and limitations associated with each type of monolith structure.80–82,54 
Monolith 
Nature 
Advantages Limitations 
O
rg
a
n
ic
/P
o
ly
m
er
ic
 
 Broad pH working range (2-13); 
 Simplicity of preparation; 
 Inertness to biomolecules; 
 Absence of adverse effects from silanol; 
 Easy to be modified; 
 Wide range of  choices in terms of surface chemistry 
resulting from diverse pre-polymerization conditions; 
 Easily  preparable under mild and facile conditions via 
inexpensive machineries (e.g.an oven and a water aspirator); 
 Swelling/shrinkage in some solvents can help in 
chromatographic separation; 
 More suited for macromolecules separation. 
 Limited mechanical stability due to 
swelling/shrinkage in some organic 
solvents; 
 Presence of  micro-pores on polymer 
surface have an adverse effect on 
separation efficiency of small molecules as 
well as peak symmetry 
 More trouble in controlling skeletal 
structure comparing to silica monoliths. 
In
o
rg
a
n
ic
 S
ili
ca
 
 Resistance to swelling/shrinkage; 
 Great mechanical properties; 
 High column efficiency  for small molecules (≥ 100 000 N/m) 
 Wide variety of highly characterized monoliths commercially 
available, together with distinct chemistries accessible for 
surface modification and ligand attachment 
 Bimodal pore structure (large surface area: ≤300 m2/g) 
 More suited for small molecules separation 
 Difficult and time consuming fabrication 
procedures; 
 Trouble to control full preparation process; 
 Time consuming post modification once 
silica monolith generally cannot be used 
directly 
 Limited pH working range (2-8) 
H
yb
ri
d
 s
ili
ca
-
b
a
se
d
 
 Ease preparation process compared to silica monolith; 
 Less shrinkage during fabrication; 
 High column efficiency (≤267 000 N/m). 
 
 Difficult to control full preparation process; 
 Possible deficient hydrolysis of Si-O-Si-C 
bonds; 
 Close pH working scope (pH 2–8); 
 Poor reproducibility and time-consuming 
preparation. 
H
yb
ri
d
 
p
o
ly
m
er
-
b
a
se
d
 
 Functional groups at the surface, so modification can be 
avoided (more suitable for separation applications than 
silica hybrids); 
 Improved organic solvent resistance and mechanical 
properties. 
 Swelling in organic solvents, with unwanted 
changes in pore architecture; 
 Mechanical instability mainly after repeated 
use. 
 
 
 
Hybrid organic-silica monoliths, can be further split in hybrid silica-based and 
hybrid polymer-based monoliths, being the former (the one attracting more attentions) 
usually prepared by sol–gel process from silica precursors containing organic groups, 
and the latter, prepared by polymerizing monomers. So, generally they can be 
prepared by i) covalent bonding, ii) non-covalent bonding between organic and 
inorganic portions, or iii) modifications on pure inorganic based-monoliths82,80. Despite 
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hybrid monolith flexibility, service longevity, exceptional biocompatibility, mechanical 
stability, ease of preparation and design at molecular level, the limitations they entail 
(Table 1.4.)  have slowed its preferential use process82,80. 
 
 
1.1.2. Surface Modification in Monoliths 
 
 
Multiple approaches have been developed over the years, and are now 
accessible for the preparation of various functionalised monoliths48,83,12,84. The simplest, 
and possibly the most straightforward methodology to tailor monoliths’ surface 
chemistry is just by choosing the suitable monomers that possess the desired functional 
groups (ionic, polar, non-polar, zwitterionic, etc.), once these groups are going to be 
exposed on the surface of the monolith after its preparation48,83. Nevertheless, every 
time a new monomer system is employed there is a need of polymerization process de 
novo optimization so that a monolith with the desired properties is attained; however 
this could end in a dull experimental procedure. Moreover as both monomers and 
crosslinkers become part of the final structure part of functional monomers added will 
be buried on the polymer bulk and not exposing its functional groups on the surface of 
the monolith for reaction48,12. Additionally proteins attachment on surface is virtually 
impossible through this strategy due to proteins denaturation into casting solution. 
Thus besides this simple but limited approach, plethora strategies were developed to 
make possible the tailoring of monolith surface functionality as user pleases48,83,12,84. One 
approach, less direct but perhaps more convenient, comprises the functionalization of a 
pre-formed monolith by post-preparation modification of reactive groups protruding 
from its surface. This type of modification, where each single reactive site provides one 
new functionality, allows the non-dependent optimization of bulk monolith properties 
and surface chemistry, enabling a onetime optimization of the monolith in question. 
The post-preparation modifications comprise the reaction of functional reagents with 
material surface groups (in case of silica-based monoliths it is first required the 
introduction of reactive sites or anchor groups for further incorporation of 
functionality to be accomplished); monomer/polymer chains grafting to or from 
monolith surface; dynamic or static coating in case of polymeric monoliths, and 
permanent or semi-permanent coating in case of silica-based monoliths. It is 
noteworthy that grafting strategy is frequently used to increment the ligand density 
(thus binding capacity) and also to improve hydrophilicity of column surface, to 
minimize non-specific interactions between analyte and monolithic media48. However 
beyond copolymerization and post-preparation modifications (covalent 
immobilization) monoliths can also be modified by entrapment or bio-specific 
adsorption of ligand85. These methodologies are reviewed in some comprehensive 
works51,12,83. 
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To these traditional methodologies used to tailor monolith surface chemistry, 
new surface functionalities can be afforded via attaching nanoparticles with a broad 
range of properties on monolith surface. These nanostructures (silica, silver, gold, 
metal oxides or polymers-based particles, or even carbon nanotubes) have been 
employed to enhance parameters as selectivity, chemical stability, and efficiency of 3D 
monolithic structure in gas and liquid chromatography, electrophoresis, and solid-
phase extraction77,76. 
 
1.2. Motivation and Aim of the Work 
 
 
Monoliths show an attractive potential towards separation, especially of 
biomolecules. Moreover the astonishing growth of biopharmaceutical industry over 
the last decade denounce the urge for the development of novel, productive and 
efficient methods of purification, namely chromatographic matrices, once 
chromatography is the most widespread used and efficient purification approach 
nowadays. 
The present work can be divided in two main parts. In a first approach a 
screening of materials processed by cryogelation was made in order to develop 
suitable monolithic structures for adenovirus purification. All structures were 
characterized physically and chemically. In the end three monolithic materials were 
elected, analysed morphologically and tested for binding adenovirus type 5 (Ad5). 
In a second approach a monolithic structure was used for the first time as solid-
phase platform for the synthesis of a small synthetic ligand specific for Green 
Fluorescent Protein (GFP). For this it was used an existing monolith previously 
developed in our lab by cryogelation. The matrix was characterized physically, 
chemically and morphologically before and after each step of the synthesis protocol to 
evaluate the presence or not of significant changes on the support during the process. 
Finally the functionalized affinity support was tested towards the target.  
In the two approaches iron oxide magnetic nanoparticles (MNPs) were 
synthesized and embedded in the selected monoliths. The respective physical and 
morphological characterization was performed and compared with the respective plain 
supports in order to analyse the changes triggered. The MNPs modified monoliths 
were analysed regarding its performance on bioseparation of the protein in study upon 
external field exposure or not. 
In brief, this work objective is the preparation of a biocompatible, 
biodegradable, robust, and efficient monolithic material, with minimal 
environmental footprint, to purify biomolecules. 
 
 
 Literature Review 
 
15 
 
 
           
Figure 1.2.- Schematic depiction of research approaches followed in present work. 
1st APPROACH: 2
nd APPROACH: 
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2.1. Materials  
 
 
2.1.1. Chemical Compounds 
 
 
Chitosan (75-85% deacylated, medium Mw), dextran (from Leuconostoc 
mesenteroides, Mw ≈150,000), acrylamide (AAm, for electrophoresis, purity ≥99%), 
poly(vinyl alcohol) (PVA, 99.0-99.8%(mol) hydrolysed, Mw 89,000-98,000), glycidyl 
methacrylate (GMA, 97%), 1,6-hexanodiamine 98%, N,N-dimethyl formamide (DMF, 
purity ≥99.8%) , phenylacetic acid 99%, iron (III) chloride hexahydrate (purity ≈98.0-
102%), iron (II) chloride tetrahydrate (purity  ≥99.0%), β-mercaptoethanol (purity 
≥99.0%), phenol (unstabilized, purity ≥99%), potassium cyanide (purity ≥96.0%), 
pyridine (purity ≥99%), glutaric dialdehyde solution 50 wt%  in water, silver nitrate 
(purity ≥99.0%), 1-pyrenemethylamine hydrochloride (purity 95%), isopropyl 
isocyanide (purity ≈97%), glycerol (purity ≥99.5%), ethylenediaminetetraacetic acid 
(EDTA) (purity ≥98.5%), bichinchoninic acid (BCA) kit and phosphate buffered saline 
tablet (PBS) were supplied by Sigma-Aldrich.  
Ammonium persulphate (APS, purity ≥98%) and N,N,N’,N’-
tetramethylethylenediamine (TEMED, purity ≈99%), methanol (purity ≥99%), 
bromophenol blue sodium salt and 2-propanol were purchased from Roth.  
N,N’-Methylenebisacrylamide (MBAAm, purity ≥98%), ninhydrin (purity 
≥99%), ammonium hydroxide (purity ≈25%), maleic acid (purity ≥98%) and 1,10-
phenanthroline 1-hydrate (purity ≥99.0%) were acquired from Fluka. 
Glacial acetic acid (purity ≥99,7%) was purchased from Fisher Chemical.  
Bacteriological Agar powder was acquired from HIMEDIA.  
β-D-1-Thiogalactopyranoside (IPTG), luria broth (LB), agarose (electrophoresis 
grade), ampicillin, glycine ultrapure for molecular biology, NZYMiniprep kit, 
tris(hydroxymethyl)aminomethane (Tris) Base ultrapure for molecular biology, and 
Greensafe were acquired from NZYTech. 
Sodium citrate dihydrate (purity ≥99%) was supplied by Merk.  
Absolute ethanol (purity ≥99.9%) was purchased from Scharlau.  
Glycine (98% purity) and hydroxylamine hydrochloride (97% purity) were 
obtained from Acros.  
Sodium hydroxide, hydrochloric acid 37%, ethylene glycol and sodium chloride 
were supplied by Panreac.  
The 30% acrylamide/bisacrylamide solution 37:5:1, sodium dodecyl sulphate 
solution 10% (SDS, 161-0416) and the Silver Stain Plus Kit (fixative enhancer 
concentrate, silver complex solution, reduction moderator solution, image 
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development reagent and development accelerator reagent) were purchased from BIO-
RAD. 
The Coomassie Plus (Bradford) assay kit was supplied by Thermo Scientific. 
Nitrogen and argon were provided by Air Liquide.  
 
 
2.1.2. Biochemical Reagents 
 
 
Albumin from bovine serum (BSA, purity  ≥98%) was purchased from Sigma. 
Recombinant green fluorescent protein rTurboGFP (FP552-Evrogen) was acquired 
from Biocat GmbH. The plasmid pET-21c containing the DNA fragment encoding for 
GFP was synthesized and subcloned by GeneartTM (Germany). Competent cells NZY5α 
and BL21(DE3), DNA marker ladder III and low molecular weight protein marker 
were purchased from NZYTech. 
DNaseI was aquired from Roche.  
Ad5 virions 10 times concentrated and 5 times diafiltrated (21st February 
DM/CP) was kindly produced and manipulated by Dr Cristina Peixoto’s laboratory on 
ITQB-UNL/IBET, Portugal. 
 
 
2.1.3. Equipment 
 
 
Stirring of the casting solutions was performed using Dragon LAB MS-H-Pro 
stirring plates.  
The lyophiliser used was a Telstar cryodos-50. 
For the swelling tests, growing assays, GFP expression, A4C7 ligand synthesis, 
and BCA assays it was used an IKA KS 4000 i control incubator shaker. 
The uniaxial compression measurements were attained using the compressive 
mode of tensile testing equipment (MINIMAT firmware v.3.1).  
An Hitachi S 2400 equipment was used for SEM micrographs acquisition. 
The amination of monoliths was performed in a Plasma system FEMTO, 
version 3, Diener Electronics.  
Hydrodynamic diameter and Zeta Potential measurements of MNPs samples 
were accomplished in a Malvern Dynamic Light Scattering (DLS) Zetasizer Nano ZS.  
For magnetite assays the pH of solutions was adjusted in a Hanna Instruments 
microprocessor-based pH/mV/°C bench meter. 
Flux measurements with and without magnet, non-specific interactions column 
testing with Ad5 and GFP, and screening assays between A4C7 ligand functionalized 
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monolith and GFP were achieved in 0.9x6.5 cm Varian columns. On virus assays all 
columns were equipped with a frit from Varian. 
The Fluorescence Microscope Olympus BX51 with an objective U-RFL-T (40x 
amplification) and U-MWB (λexc= 460-490 nm; λem = 515-570 nm), an U-RFL-T lamp, an 
objective Uplam FLN, and Cell F software was employed to confirm the presence of 
the ligand into the functionalized supports.  
The isolation of pET-21c plasmid was fulfilled with Sigma 3-18K centrifuge. The 
plasmid DNA (pDNA) was evaluated through agarose gel electrophoresis, by using a 
BIO-RAD electrophoresis chamber with BIO-RAD PowerPac Basic power supply. Gel 
visualization was possible with KODAK 1D 3.6 software through UVITEC 
Transilluminator. For pDNA concentration determination samples were introduced in 
NanoDrop ND-1000 v3.5.2 spectrophotometer. 
E.coli cells grown were collected with Herceus Multifuge X3R centrifuge 
(Thermo Scientific), lysed with Thermo Scientific French press and ultracentrifuged in 
a Beckman Optima LE-80 (rotor 45TI). For the SDS-PAGE gels electrophoresis it was 
used the BIO-RAD Mini-Protean Tetra System, for gel revelation it was used the 
KODAK 1D 3.6 software through UV UVITEC Transilluminator. 
Absorbance readings were performed in Greiner 96-well UV half area, or 
Sarstedt 96 well flat transparent microplates (colorimetric assays), and fluorescence 
readings were performed in brand black immunograde 96-well microplates (VWR). 
The spectrophotometric and spectrofluorometric measurements were conducted on a 
Tecan’s microplate reader Infinite F200 with respective brand filters (λexc=485–505 nm; 
λem=535-560 nm, 492 nm and 560 nm) with exception for E. coli growth monitoring 
once it was used a spectrophotometer PerkinElmer Lambda 35 UV/Vi Spectrometer 
(600 nm).  
Nanosight nanoparticle tracking analyser was used toanalyse samples from 
virus screening assays.  
Length measurements were performed with a SOMET vernier caliper or a ruler. 
 
 
2.2. Methods 
 
 
2.2.1. Monolith Preparation  
 
 
Monoliths preparation by cryogelation process accompanied by freeze-drying 
method involved the former brewing of distinct casting solutions, with different 
composites and compositions. Table 2.1. shows in detail the composition of the casting 
solutions that were prepared.   
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Table 2.1.- Casting solutions processed for monoliths preparation. All casting solutions were 
formulated with 3 mL of distilled water per monolith. Polymers and/or monomers content in 
every 2.9%(w/w) casting solution is 90mg. Conversely in PVA:GMA 79:21%(w/w) casting it  is 
101mg, in AAm:MBAAm:GMA 95mg/210mg, and in agarose:AAm:GMA and 
dextran:AAm:GMA 142 mg/172 mg. 
Materials Proportions %(w/w) Concentrations %(w/w) Freezing Temperature (°C) 
Chitosan 100 
2.9 -20 and -80 
2.0 -20 and -80 
Chitosan:PVA 
50:50 2.9 -20 and -80 
33:67 2.9 -20 and -80 
Chitosan:GMA 89:11 2.9 -20 and -80 
PVA:GMA 
79:21 3.3  -20 and -80 
89:11 2.9 -20 and -80 
AAm:MBAAm:GMA* 78:17:5 
3.1 -20 
6.5 -20 
Agarose:AAm:GMA 
56:7:37 4.5 -20 
58:12:30 5.4 -20 
Dextran:AAm:GMA 
56:7:37 4.5 -20 and -80 
49:14:37 4.5 -80 
58:12:30 5.4 -20 and -80 
52:17:30 5.4 -80 
PVA 100 2.9 -20 and -80 
 
 
Chitosan-based casting solutions were prepared based on a recent work27 with 
little increment on “crosslinker” (from 2%, in relation to polymers and/or monomers 
mass, to 5.6%). In case of sole chitosan-based solutions two types were prepared, based 
on the polysaccharide concentration in the 3 mL final solution (2.0 and 2.9%(w/w)). 
Blended solutions of chitosan with GMA and PVA in various ratios were also brewed. 
Chitosan was varied in a range of 33-89% (w/w), PVA in a range of 0-67%(w/w) and 
GMA in a range of 0-11%(w/w). It is noteworthy that all chitosan-based casting 
solutions were prepared with 3 mL of acetic acid acidified water 1%(v/v), all the 
remaining solutions are prepared with 3 mL of distilled water. 
Regarding PVA:GMA-based solutions  PVA varied between 79-89%(w/w) and 
GMA between 11-21%(w/w). A 100%(w/w) PVA casting solution was also prepared 
and maleic acid was used as the crosslinker in 2%(w/w).  
For the preparation of supermacroporous polymeric matrices acrylamide, 
agarose and dextran-based castings were also elaborated. With respect to acrylamide 
monoliths two casting types were prepared varying composites content in solution 
from 3.1-6.5%(w/w). Monomers and crosslinker ratios for both casting types are based 
on a previously described work9.  For Agarose-based monoliths acrylamide content 
varied from 7-12%(w/w), GMA from 30-37%(w/w) and agarose from 56-58%(w/w). For 
Dextran-based monoliths acrylamide content varied between 7-17%(w/w), GMA 
between 30-37%(w/w) and dextran in a range of 49-58%(w/w).  
*MBAAm is used not only as a “crosslinker” but also as a monomer. 
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All casting solutions were formulated into individual 1.4x4.9 cm plastic tubes 
where they were submitted to different temperatures and stirring velocities, depending 
on their viscosity and solubility in water. PVA-based solutions were subjected to 
stirring rates of ~500 rpm and temperatures of 85-90°C. Chitosan-based solutions, 
depending on their chitosan content, have been submitted to different stirring rates. In 
fact, the ones with uppermost chitosan fraction required a superior rate and a higher 
stirring temperature (70-85°C) due to casting higher viscosity. Dextran and acrylamide-
based solutions were stirred at room temperature and in contrast agarose-based 
solutions were subjected to a stirring temperature of 40°C. The objective of stirring was 
to efficiently homogenize the casting solutions for further freezing and lyophilisation 
procedures. Thereunto globally the stirring rate varied between 300-800rpm, the 
stirring temperature between 20-90°C and stirring time between 1-3 days. When 
homogenized initiator (APS (42 µl)) and catalyst (TEMED (23 µl)), were added to 
promote the “crosslinking” and/or polymerization process (all solutions were 
ressuspended or mingled to assure the maximum contact of TEMED and APS with 
solutions composites). While the “crosslinking” process were performed at 0°C during 
30 minutes for chitosan-based and PVA:GMA solutions, for dextran ones it occurred 
during 30/45 minutes. In case of agarose-based and AAm:MBAAm:GMA solutions this 
process occurred for 30 minutes under stirring, but at room temperature. For 
100%(w/w) PVA the initiator and catalyst are added under stirring at 90°C and the 
reaction was continued for 90 minutes. 
Finally all solutions were frozen at -20°C and/or -80°C during 24h and then 
lyophilized for another 24h or until dry state. 
 
 
2.2.1.1. Smart Monolith Preparation 
 
 
Some specimens from 2.2.1. were prepared in the presence of magnetic 
nanoparticles. The same quantity of “crosslinker”, polymers and/or monomers was 
dissolved not on 3 mL distilled water but on 2 mL. The remaining 1 mL was added as 
MNPs solution (24-67 mg/mL). Complete homogenization took 3-4 days to be 
accomplished.  
 
2.2.1.1.1.  MNPs Synthesis 
 
Magnetic nanoparticles were synthesized at room temperature by co-
precipitation method of FeCl3 and FeCl2 salts with a molar ratio of 2:1, as described 
elsewhere86.  The procedure implies mixing 115 mL of distilled water with 60 mL of 
ammonia hydroxide 25% and further nitrogen gas inertization of vessel cell (~15 
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minutes) under stirring (1500 rpm). Hereafter a freshly prepared iron solution (5.438g 
of FeCl3.6H2O plus 2.0g of FeCl2.4H2O in 25 mL of distilled water) was added dropwise 
to the N2 purged ammonium solution. Then the reaction was extended for 2 hours 
under maximum stirring (2000 rpm) and inert atmosphere (N2 ongoing bubbling). 
Once completed the synthesis, ammonium hydroxide traces were completely removed 
from MNPs solution by washing several times with distilled water using magnetic 
field for separation. MNPs solution concentration was measured by subtracting the 
weight of empty flask from a flask with overnight dried MNPs solution. 
 
2.2.1.1.1. 1. MNPs Characterization 
 
MNPs physico-chemical properties (hydrodynamic diameters, polidispersity 
and zeta potential) were determined by DLS. For these analysis samples with a 
concentration of 0.05 mg/mL in distilled (pH5.8) water were prepared.   
 
2.2.1.1.2. MNPs Leaching Assessment 
 
The amount of iron-oxide particles released during the A4C7 ligand synthesis 
or during screening assays was determined by a colorimetric assay, the magnetite test. 
Its principle relies on magnetite ionization to Fe3+ ions under acidic conditions, then its 
reduction to Fe2+ by hydroxylamine hydrochloride and finally its reaction with 3 
molecules of 1,10-phenantroline with Fe(o-Phen)32+ complex formation, a characteristic 
orange-red coloured complex absorbing at 509nm87. Colour intensity is directly 
proportional to Fe2+ amount present in solution (Figure 2.1.). The sample analysis 
procedure to estimate iron release involved, as described elsewhere88, the addition of 
100 µl sample, 500 µl of concentrated HCl and 500 µl of 1.44M hydroxylamine to a test 
tube and solutions rest in the dark (15 minutes). Then 1 mL of 0.0126M o-
phenanthroline and 250 µl of 12M NaOH were added, and finally the pH was adjusted 
to ~4.0 with 0.5M sodium citrate buffer. The absorbance of 200 μl samples was read at 
492 nm. A calibration curve was constructed with several concentrations of Fe3O4 in 
distilled water subjected to same treatment.  
 
 
 
Figure 2.1. – Reaction mechanism in the base of Magnetite Method. 
Hydroxylamine 
hydrochloride 
1,10 – Phenantroline 
Fe(o-Phen)3
2+ 
complex 
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2.2.2. Monoliths Characterization – Chemical Properties 
 
 
Each one of three chopped samples from each specimen with ~0.7 cm height 
was immersed in 30 mL flasks, with 10 mL of distinct pH solutions: pH 3, 7.4, or pH 11. 
The submerged sample behaviour and macroscopic modifications were recorded and 
registered during two whole weeks. 
 
To determine the water uptake ability of materials at different pHs, swelling 
tests with dynamic character were performed. Dry samples of each monolith specimen 
were weighted (wdry) and immersed in 30 mL flasks with 10 mL of PBS. At specific time 
intervals, each sample was removed from swelling medium, slightly wiped with soft 
tissue to remove excessive water at the surface, and weighted (wwet). Following 24 
hours, the scaffold samples mass have reached a plateau value and were conveyed to 
acetate buffered saline solution 0.1M, pH5. After further 24 hours, the polymeric matrix 
mass have reached another plateau value, and samples were then transferred to a new 
PBS solution. After another 24 hours one more plateau value was reached and each 
sample was conveyed to the last swelling medium, a fresh pH5 acetate buffer, and was 
left for the last 24 hours to reach the last plateau of the study. Therefore during one 
week the dynamic swelling and shrinking was studied. The procedure occurred at 
~28°C under stirring (100rpm). Hereupon, the swelling degree or swelling ratio (W) of 
the studied monoliths was defined as the ratio of weight increase to initial weight, as 
stated by the following equation (1): 
 
 ( )  (
         
    
)                               (1) 
 
Where wwet denotes weight of monoliths after immersion onto swelling 
medium, and wdry stands for weight of monoliths before immersion onto swelling 
medium89,90.  
Swelling kinetic analysis was made by measuring water uptake capacity over 
time (≈25°C) through a conventional gravimetric procedure91.  Monolith sections were 
dried in the oven (60°C), weighted and plunged in deionized water. Samples were 
weighted at the first two halves a minute and then per minute weightings were 
executed until 10 minutes completion. The water uptake capacity was finally 
determined (2)91: 
 
  ( )  (
       
  
)                               (2) 
 
Where wu denotes water uptake capacity, wt the wet weight at particular time 
intervals, and we the water weight into the swollen gel at swelling equilibrium.  
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2.2.3. Monolith Characterization – Morphological and Mechanical 
Properties 
 
 
The water fluxes were determined at ~22°C under atmospheric pressure. All 
samples were mounted in a 0.64 cm2 effective area and 6 cm height chromatography 
column. This column in turn is seized by a clamp added by a holder and supported in 
a stand. The dry sample inside the column is wetted with 1 or 2 mL of distilled water 
depending on its swelling capacity, and then the time that 1 mL of clean distilled water 
lingers to cross the column all the way out is recorded three times with each three 
samples of the same specimen27. 
 
Regarding dry and wet apparent densities, their values were determined 
through the ratio of dry and wet weight respectively with respect to the corresponding 
volume92. Regarding monolith true and relative densities, they were determined by 
equations (3) and (4) as described elsewhere93. Height (100%) was set as 2 cm. Equation 
(5) gives information about pore volume94.  
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The density corresponds to   (g/cm3), polymer fraction to fpolx (%(w/w)), and 
total pore volume to Vp (cm3/gsupport). Regarding densities and Vp, although the 
method used is simple and fast, it comprises a rough estimation of its value as 
significant errors can be made during determination of monolith volume92. For 
monoliths designed for GFP protein purification, density was measured in PBS 
solution. Weighings were done at room temperature. 
 
Specimens’ porosity was estimated applying a fluid displacement measurement 
method, a modified Archimedes principle technique based on published methods95,92. 
First the volume of cylindrical samples (~0.5 cm height) was registered (Vmonolith). Then 
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each individual sample was immersed in a graduated cylinder filled with ~10 mL 
ethanol (displacement liquid), previously weighted (w1). Then a series of brief 
evacuation-repressurization cycles were performed to force ethanol into monolith 
pores. This cycling is continued for ~15 minutes and then the sample is kept under 
vacuum until it reaches the bottom of the graduated cylinder, no air bubbles are seen 
emerging from the support neither in its surface. The procedure can take just one hour 
or few days depending on monolith specimen. At last, the ethanol-impregnated 
scaffold is removed from graduated cylinder and the weight of ethanol left in the 
cylinder is set as w2. See equation (6). 
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To examine and study the mechanical response of supports, all specimens were 
subjected to macro-scale mechanical experiments, specifically uniaxial compression. 
Those analyses were conducted at room temperature using tensile testing equipment. 
Unhewn prepared monoliths are sliced in cylindrical chops with 0.75-1.20 cm in 
diameter. The distance between clamps is determined by specimens’ length (0.53-1.30 
cm). The motor speed was set at 1 mm/min and the maximum displacement of 
compression varied between 5-13 mm depending on sample width, a full scale load of 
20N was used. These measurements were performed with dry and hydrated samples. 
As such, for testing wet supports, samples of each specimen are soaked in distilled 
water (or PBS in case of monoliths towards GFP purification) for 5 minutes, rinsed and 
then set on the apparatus. 
It is obtained an assembly of load versus compression charts, which are 
converted to stress versus strain curves applying equations (7) and (8)27:  
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Here F corresponds to the applied force, A to the cross-sectional area, ∆l to the 
change in length and L to clamps distance.  The compression modulus is then 
calculated as the slope of the initial linear portion of the stress-strain curve. 
 
Monolithic morphology was accessed by scanning electron microscopy (SEM). 
An accelerating voltage was set to 15 kV. All samples were frozen and fractured in 
liquid nitrogen for cross-sectional analysis, mounted on aluminium stubs using carbon 
discs (D-400, Neubaeur Chemikalien), and gold-coated by sputtering before analysis. 
B 
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Then micrographs were examined using the image analyser software ImageJ® 20 to 
determine the average pore size diameter96. 
 
In case of magnetic monoliths, to evaluate their magnetic response ability, two 
monolith cylindrical pieces were chopped and its distortion and shape recovery were 
monitored during 1 hour with a ruler help. Four different magnetic fields were tested: 
0.25T, 0.5T, 0.53T and 1.5T.   
 
 
2.2.4. Screening of Non-Functionalized Monoliths with Ad5 Virus
 
 
To check for non-specific interactions between Ad5 virions and the different 
monolithic materials screenings assays were performed in ITQB-UNL/IBET, Portugal, 
under Dr. Cristina Peixoto supervision. All columns were first washed and regenerated 
alternating five times 2 mL of regeneration buffer (1M NaOH 30% isopropanol) with 2 
mL of distilled water, then they were equilibrated with 20mM Tris-base 150mM NaCl 
pH8 buffer (5 mL) and stored in the same buffer. The assay itself compromised the 
loading of each column with 1 mL of previously 3x diluted Ad5 particles (~1.45x1011 
TP/mL) followed by its washing with 2 mL of elution buffer (20mM Tris, 150mM NaCl, 
pH8). Virus recovery was calculated (9)97.  
 
         ( )  
             
       
                           ( ) 
 
 
 
 
 
 
 
 
 
 
 
 Experimental 
 
29 
 
2.2.5. Production of GFP Containing-Crude Extracts  
 
 
The standard procedure used for large scale production of GFP is deeply 
summarized on Figure2.2. and is explained in detail in the following sections. 
 
 
Figure 2.2. – Diagram of summarized GFP large scale production protocol. 
 
 
2.2.5.1.  Preparation of LB Medium and LB Agar Plates with 
Ampicillin 
 
 
For the bacterial culture it was prepared the LB medium by adding 20 g to 800 
mL MiliQ water. The LB agar involved the dissolution of 7.5 g of LB and 4.5 g agar in 
300 mL of MiliQ water in a Schott flask. Afterwards, the LB and LB agar were 
autoclaved (120°C, 20 minutes).  Later, LB agar medium was cooled to ~50°C (avoiding 
medium solidification) and 500 µl of 100μg/mL ampicillin were added under sterile 
conditions. The importance of cooling down LB agar medium before antibiotic 
addition is connected to its degradation at high temperatures98. After ampicillin 
addition, the medium was spread in sterile Petri dishes (~20 mL of medium per Petri 
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dish) under sterile conditions. After solidification all plates were kept at 4°C wrapped 
in aluminium foil98. LB liquid medium was kept at room temperature. 
 
 
2.2.5.2.  Transformation of pET-21c Plasmid in NZY5α Competent 
Cells 
 
 
The pET-21c plasmid, synthesized by GeneartTM carries the gene that encodes 
for GFP protein. For transformation of the E. coli NZY5α competent cells with pET-21c  
supplier instructions (NZYTech) were followed. So first NZY5α cells (60 μl) were 
thawed on ice, and then mingled with 10 µl of plasmid solution, gently mixed and 
incubated on ice for 30 minutes. Subsequently, cells endured a 30 second and 42°C 
heat-shock in a water bath followed by an immediate plunge on ice for 2 minutes. 
Afterwards, 940 μl of LB medium were added to the cells and the final solution was 
shaken during 1 hour (210rpm, 37°C). Later 50 μl and 100 μl of the transformed cells 
volume were spread on LB agar plates containing ampicillin antibiotic. In order to 
concentrate the cells, the remaining volume (860 μl) of cell culture was centrifuged 
(1850xg, 5 minutes) and 700 μl of the supernatant medium was discarded. The 
concentrated cells were ressuspended in the remaining supernatant volume and spread 
on LB agar plates that were incubated overnight (37°C). Regarding negative and 
positive controls they were prepared with 20 μl of NZY5α cells and without any 
plasmid addition or adding 1 μl of pNZY28 plasmid (0.1ng/µl), respectively. 
 
 
2.2.5.3.  Isolation and Purification of pET-21c pDNA  
 
 
The isolation and purification of pET-21c pDNA whole procedure began with 
the drawing up of three pre-inoculum test tubes: 2x pET-21c and a negative control. 
Each tube held 6 µl of ampicillin (100 μg/mL), 6 mL of LB medium and a single isolated 
colony of transformants (2.2.5.2.). For the negative control test tube no colony was 
included. All tubes were incubated overnight (210rpm, 37 °C). The isolation and 
purification itself was executed using NZYMiniprep kit and the supplier instructions 
were followed. As pET-21c is a low-copy number plasmid, showing low basal 
expression levels99, cells and lysis buffers volumes were doubled for a more effective 
process. Thus procedure began with cell harvest after overnight growth: 6 mL of 
NZY5α cells culture were centrifuged (1850xg, 2 minutes) and then the supernatant 
was discarded. This was followed by a step of cell lysis: the obtained pellet was 
ressuspended with 500 μl of buffer A1 (RNase A) by vigorous vortexing, then 500 μl of 
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buffer A2 (SDS, NaOH) were added, the solution was mingled gently by inverting the 
tubes ~8 times, and was then incubated at room temperature (4 minutes). After 
incubation, 600 μl of buffer A3 was added and solution was mixed by gently inverting 
the tubes ~8 times. Then to clarify the lysate the tubes were centrifuged (1850xg, 10 
minutes) and the supernatant was poured onto a NZYTech spin column placed in a 2 
mL collection tube to allow pDNA binding. The column was centrifuged (1850xg, 2 
minutes) and the flow-through was forgone. Then it was time for silica membrane 
washing: 500 μl of pre-warmed (50°C) buffer AY were added into the column and 
centrifuged (1850xg, 2 minutes). The obtained flow-through was discarded. Then it was 
added 600 μl of buffer A4 (with previous ethanol addition) into the column and 
another centrifugation step followed (1850xg, 2 minutes). Once more the flow-through 
was discarded. Before pDNA elution silica membrane had to be dried. So NZYTech 
column was inserted into a new empty 2 mL collecting tube and centrifuged (1850xg, 3 
minutes). Once dried the NZYTech column was placed into a clean 1.5 mL 
microcentrifuge tube for the first elution step to begin: addition of 30 μl of pre-warmed 
(65°C) MilliQ water at the central part of the tube, further incubation in a 37°C water 
bath (1 minute) and centrifugation (1850xg, 2 minutes) at room temperature. The first 
fraction of the eluted pDNA was then maintained at 4°C. This procedure was repeated 
for the second elution step although 50 μl of MilliQ water were added. Then the two 
eluted fractions were kept at -20°C for further usage. 
 
 
2.2.5.4.  Spectrophotometric Quantification of pET-21c pDNA 
 
 
Through spectroscopic analysis it is possible to quantify the pDNA present in 
each eluted fraction obtained (2.2.5.3.) and to ascertain its purity. For that 1µl sample of 
1st and 2nd elutions was placed onto the receiving fiber of NanoDrop 
Spectrophotometer. Then a spectrum scan between 220-280nm was realized with the 
direct obtainment of sample concentration and Abs260nm/Abs280nm, Abs260nm/Abs230nm 
ratios. In fact determination of DNA concentration is related with absorbance at 
260nm, where for 1 cm path length the absorbance at 260nm equals the unit for 
50µg/mL of double stranded DNA (dsDNA), as is stated by equation (10), being D the 
dilution factor100:  
 
[     ]        ⁄                                     (  ) 
 
The DNA purity is given by the ratio Abs260nm/Abs280nm that should be ~1.8 in 
case of a pure DNA samples. Abs260nm/Abs230nm ratio is used as a secondary measure of 
nucleic acid purity; its values generally vary between 1.8-2.2100. 
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2.2.5.5.  Agarose Gel 
 
 
For further examination of the two eluted fractions of pET-21c plasmid agarose 
gel electrophoresis was employed. This analysis comprised evaluation of DNA in 
terms of its conformation. In fact DNA can assume three different conformations: 
closed circle supercoiled form (SC), nicked circular form (NC) and linear form (LF) that 
will determine its mobility in the gel101. The DNA form that presents a higher 
electrophoretic mobility is SC followed by LF and finally NC. A 0.8% agarose gel was 
prepared by addition of 0.80 g of agarose to 100 mL of 1x TAE (Tris-acetate-EDTA) 
buffer pH8.5. For a 50x TEA buffer it was added 121g of Tris, 28.55 mL of glacial acetic 
acid, 50 mL of 0.5M EDTA (pH8.0) and distilled water up to 500 mL, pH was adjusted 
to 8.5, then the respective dilution was made for a 1x buffer. The Agarose and TAE 
buffer mixture was microwave heated (~2 minutes) until complete agarose dissolution. 
Then, the solution was shed in a proper container with a comb allowing complete 
solidification of agarose with creation of the desired number of wells. Samples were 
prepared adding 2 µl of each elution fraction in distinct eppendorfs plus 5 µl of loading 
buffer blue juice (65%(w/v) sucrose, 10mM Tris-HCl (pH 7.5), 10mM EDTA, and 
0.3%(w/v) bromophenol blue). Same treatment was executed for DNA marker. After a 
spin down samples were added to the gel and the running was extended for 60 
minutes, 100 V. Gel staining was performed within a solution of 11 µl of GreenSafe in 
100 mL of 1x TAE buffer under gentle agitation (1h). Later the gel was photographed. 
 
 
2.2.5.6.  Large Scale Expression of GFP  
 
 
2.2.5.6.1. Transformation of E. coli BL21(DE3) Competent Cells with pET-21c 
 
E. coli competent BL21(DE3) cells were transformed with positive pET-21c clone 
as outlined in 2.2.5.2. using the pDNA isolated and purified on 2.2.5.3.. The negative 
control was performed without plasmid addition and the positive one by adding 1 μl 
of pUC19 plasmid to 20 μl of cells.   
   
2.2.5.6.2. Cell Growth and Expression of GFP 
 
The large scale production of GFP requires two inocula. First 1L of LB medium 
was formulated (2.2.5.1.) in a 2L erlenmeyer. Then a pre-inoculum was prepared in a 
sterile test tube by addition of 6 mL LB, 6 μl ampicillin (100μg/mL) and a single colony 
from the recently transformed BL21(DE3) cells (2.2.5.6.1.). Negative control received no 
colony. Both preparations were kept for 7 hours (37 °C, 210 rpm) in orbital shaking. 
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Later 50 mL LB, 50 μl of ampicillin (100μg/mL) and 1 mL of pre-inoculum were added 
to a 250 mL erlenmeyer with posterior overnight incubation (37°C, 210 rpm) (inoculum 
was prepared). Then the large scale expression began by adding to the 1L of LB 
medium prepared, 1 mL of ampicillin (100µg/mL) and 10 mL of inoculum,  keeping it 
with orbital shaking (220 rpm, 37°C). As according to small scale studies reported by 
Dr. Ana Pina102 the optimal conditions for GFP production comprises addition of 1mM 
IPTG (inductor) at OD600nm 0.6-0.8, and orbital shaking (220 rpm, 37°C) during 22 hours, 
the large scale expression was conducted with the mentioned conditions. So, after 
preparation of the last inoculum (in 2L shaken flask) cellular growth was monitored by 
optical density measurements. Once reached an OD600nm 0.6-0.8, GFP expression was 
induced with 1 mL IPTG. So during growth and expression, ~5 mL aliquots of cell 
culture after 2 hours, 2h45min, 3h15min, 3h30min, 3h50min, 4h05m, 6h05min, 8 hours, 
9h05 and 22h30m inoculation were taken and analysed optically and/or 
fluorimetrically and by SDS-PAGE. The induction occurred after 4h05min growth.  
 
2.2.5.6.3. SDS-PAGE Analysis for Evaluation of GFP Production 
 
To evaluate GFP amount produced during time course there was a need to 
normalize sample volumes in order to introduce a fair quantity of cells in each one. 
Normalization was applied according to the ratio between 1.2 and respective optical 
density value of each sample. Then normalized volume samples were centrifuged 
(1850xg, 5 minutes). Supernantant was thrown out and 15 μl of sample buffer (5 mL of 
0.5M Tris-HCl pH 6.8, 2 mL of 100% glycerol, 4 mg Bromphenol blue sodium salt, 8 mL 
of 10% SDS, 1 mL β-mercaptoethanol and distilled water up to a final volume of 20 
mL) was used to ressuspend the pellet. After spun down samples were dipped in a 
boiling water bath (2 minutes). The protein marker (5 μl) was subjected to the same 
treatment but 5 µl of sample buffer were added.  After this procedure all samples, 
including marker were placed in a 12.5% acrylamide gel. This whole gel assembles two 
different gels: a bottom one (running gel) and a top one (stacking gel). Each gel was 
prepared according to a standardized protocol (table 2.2.).  
After addition of running gel solution to the glass plates casting moulding ~1 
mL of 2-butanol 99% was added on top of it promoting a flat surface generation. Then 
the gel was polymerized for 30 minutes. When finished the butanol solution was 
removed and the gel washed with distilled water. Afterwards the 5% stacking gel was 
formulated and polymerized (30 minutes) on the top of the former along with the 
moulding wells comb. The running apparatus was then assembled, electrophoresis 
buffer (0.25M Tris Base, 1.92M Glycine, 0.1% SDS pH 8.3, 10x diluted) added and 15 µl 
samples were pipetted to each well to finally run at 150 V, 250 mA (1h). The staining (1 
g Coomassie Blue, 15 mL glacial acetic acid, 90 mL methanol and distilled water up to 
200 mL) was 30 minutes long and destaining (75 mL glacial acetic acid, 450 mL of 
methanol and distilled water up to 1L) occurred overnight.  
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Table 2.2. – Required volumes to prepare one 12.5% Acrylamide gel. 
Reagents Running Gel Volume (ml) Stacking Gel Volume (ml) 
Solution I (3M Tris-HCl, pH 8.8) 0.75 - 
Solution II (0.5M Tris-HCl, pH 6.8) - 0.45 
Solution III (Acrylamide/Bisacrylamide) (30:0.8) 2.08 0.3 
10% SDS 0.05 0.018 
Distilled Water 2.1 0.94 
10% APS 0.038 0.0135 
99% TEMED 0.0025 0.002 
 
2.2.5.6.4.  Evaluation of GFP Amount by Fluorescence Measurements 
 
The GFP flurescence of each sample collected at a precise time after induction 
was measured through addition of 200 µl of sample in each microplate well. The 
fluorescence was evaluated using ʎexcitation=485 nm and ʎemission=535 nm and a gain of 41. 
 
2.2.5.6.5. BL21(DE3) Cells Fractionation 
 
Aiming the acquirement of a soluble GFP crude extract from the large scale 
expression, cells were crumbled and further subjected to some centrifugation steps. So, 
once protein expression is terminated cells culture was centrifuged (11000xg, 20 
minutes, 4°C). Supernatant was disposed and pellet ressuspended on 10 mL PBS 
(10mM sodium phosphate, 150mM NaCl, pH7.4), the binding buffer required for 
screening assays. Then ressuspended cells underwent a series of freeze/thaw cycles 
weakening its membrane to consequently improve fractionation effectiveness. The 
disruption was a mechanical step executed by a French Press in which cells passes 
three times through a narrow valve under outer 1280 psi. Afterwards the lysate sample 
made contact with DNaseI (15 minutes) in order to reduce its viscosity, and was 
centrifuged at 4°C (11000xg, 15 minutes). The pellet fraction was ressuspended in 15 
mL PBS and 500 µl stored for further SDS-PAGE and fluorimetric analysis. An aliquot 
of supernatant was also collected and the remaining further ultracentrifuged 
(42000rpm, 1h30m, 4°C). The resultant pellet was ressuspended in 26 mL PBS and 500 
µl stored for further SDS-PAGE (2.2.4.6.3.) and fluorimetric analysis (2.2.4.6.4.). 
However, in the present case the aliquots volumes used for SDS-PAGE analysis were 
normalized according to the final volume of the samples after each step.  Then, the 
normalized aliquot volumes from each step of cells disruption were mixed with 5 µl of 
sample buffer and then transferred to the respective well.    
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2.2.5.6.6. Soluble Crude Extract Quantification in terms of GFP and Total Protein Content 
 
The quantification of GFP and total protein was assessed by GFP fluorescence 
and BCA colorimetric assay. GFP fluorescence enabled the quantification of GFP 
protein through fluorescence intensity measurements as described in 2.2.5.6.4.. It is 
noteworthy that mentioned measurements required a calibration curve obtained 
through the measurement of different pure GFP concentrations within the range 10-6-
10-1mg/mL. The quantification of total protein through BCA assay involved the creation 
of a calibration curve using BSA as standard protein. The range of concentrations was 
0.2-1.0mg/mL. To perform the BCA assay, 25 µl of each sample (calibration curve and 
crude extract) was pipetted to each microplate well. Then, 200 µl of light green BCA 
working reagent formulated with mixing of 50 parts of reagent A with 1 part of reagent 
B was added to each wells. Then follows a 30 minutes incubation (37°C) finalized by 
samples absorbance measurement at 560nm. 
 
 
2.2.6. Chitosan-based Monoliths Fuctionalization Towards GFP Protein 
 
 
2.2.6.1.  Monoliths Amination by Plasma Technology 
 
 
The objective of this step was to fill the utmost surface of monolith with amine 
free groups. Thus, an oil bath was heated up (140-150°C) under stirring to ensure a 1,6-
diaminohexane temperature on the whole flask of ~130°C. As 1,6-diaminohexane have 
a reduced vapour pressure (0.12 mmHg at 25°C103, 1 mmHg at 43°C)104 and only boils at 
204-205°C at 1 atm103 a proper preheating and system isolation were strongly required. 
Therefore aluminium foil was used to fully isolate all system i.e., the 1,6-
diaminohexane flask and the tubing connecting the flask and plasma chamber. A heat 
gun was used (~180°C) to maintain the connecting tubing at a minimum temperature 
of ~160°C thereby assuring the entrance of 1,6-diaminohexane into the chamber  at gas 
state. All samples were placed in wire lace made boxes and then introduced into the 
plasma chamber. The vacuum bomb was turned on, assuring a negative pressure on 
the chamber, and later an inertization step with a continuous flow of argon gas was 
conducted (~2 minutes). This was accomplished in order to minimize all trace amounts 
of air and moisture inside the chamber. Finally, the reaction was performed (33 
minutes). During the first 3 minutes of treatment, argon gas flow was adjusted to keep 
a constant pressure of 0.3 Torr inside the chamber and a power of 60 W was applied to 
the equipment ensuring the formation of radicals at the surface. After those 3 minutes 
argon entrance is sealed and 1,6-diaminohexane enters the chamber reacting for 30 
minutes at the same power.  Once finished the experiment, the plasma chamber was 
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ventilated and the samples withdrawn and stored. The apparatus is schematically 
shown on figure 2.3. This method is based on a recent work79. 
 
 
 
Figure 2.3. – Layout of Amination apparatus used for monolithic samples: argon gas bottle (1), 
gas 2 manometer (2), vacuum pumb (3), plasma chamber (4), high frequency generator (5), heat 
gun (6), stirrer hot plate (7), 1,6-diaminohexane vessel (8), gas 1 manometer (9).   
 
 
2.2.6.1.1. Evaluation of Amine Groups Content by Kaiser Test 
 
The amount of free amine groups at monoliths surface was ascertained through 
a colorimetric assay, Kaiser test. This test is a qualitative one and is based on ninhydrin 
reaction with primary amines that origins an intensely blue/purple pigment (figure 
2.4.). The monolith is soaked in 1.5 mL distilled water and then 50 µl of each following 
solutions are pipetted over the sample: 80% crystalline phenol in ethanol (w/v), 
2%(v/v)  0.001M aqueous solution of potassium cyanide in pyridine and 5% ninhydrin 
in ethanol (w/v). Then follows a 5 minutes plunge on a boiling water bath (100°C). The 
calibration curve was realized by measuring the absorbance (560nm) of standard 
solutions of glycine (0–5μmoL/mL).  
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Figure 2.4. – Kaiser test reaction. Compound 1 absorbs at 570 nm. 
 
 
2.2.6.2.  Aldehyde Groups on the Surface of Previously Aminated 
Monoliths  
 
 
In order to move from an aminated surface to an aldehyde one, a reaction 
between the free amine groups and an aldehyde containing compound must occur. 
Glutaraldehyde was chosen as aldehyde containing compound, leading to a 
nucleophilic addition reaction with imine formation to take place. First it was prepared 
a 5%(v/v) glutaraldehyde solution to which was added 1M NaOH in order to respect a 
glutaraldehyde/NaOH ratio of 50/3. Then the monolith was added to the yellowish 
solution and the reaction was sustained for 1 hour (200 rpm, 30°C). At the end the 
monolith was washed with distilled water until clear water achievement.     
 
2.2.6.2.1. Qualitative Analysis over Aldehyde Functionalization 
 
The silver mirror test that is performed by Tollens’ reagent reveals the presence 
of aldehyde groups through a silver mirror or a brown precipitate. Tollen’s reagent, an 
alkaline solution of ammoniacal silver nitrate, contains a weakly oxidizing ion 
([Ag(NH3)2]+(aq)) which precipitates out metallic silver in the form of a silver mirror, 
that covers the inner surface of the receptacle. An aldehyde is oxidized to a carboxylic 
acid while the Ag1+ ion is reduced to silver metal. To prepare Tollens’ reagent first a 
flask was cleaned with 3M NaOH, then it was added 2 mL of 0.2M AgNO3 followed by 
a drop of 3M NaOH and afterwards 2.8% NH4OH was added dropwise under stirring 
until almost all precipitate of silver oxides has dissolved. To totally remove the 
precipitate, 8.8% NH4OH was added dropwise. The freshly prepared Tollens’ reagent 
was ready to use, being 1 mL then added to each monolith sample. The positive control 
was performed with 1 mL of glutaraldehyde and the negative control with unmodified 
- H2O
+ H2O
Ninhydrin
+
Ninhydrin 
Ruhemann’s Purple (compound 1) 
 Experimental 
 
38 
 
monolith samples. After Tollens’ reagent addition solution was vigorously stirred and 
heated with a lighter. 
 
 
2.2.6.3.  A4C7 ligand Solid-Phase Synthesis on Monolith Platform  
 
 
The ligand with affinity towards GFP was developed in Dr. Cecília Roque’s 
laboratory by Dr. Ana Pina and is reported in her PhD thesis102. The ligand is 
denominated A4C7 and was obtained by solid-phase (agarose) combinatorial synthesis 
of a library of affinity ligands based on Ugi reaction. This type of reaction is a one-pot 
multicomponent reaction involving four different components: an aldehyde, an amine, 
an isocyanide and a carboxylic acid. In case of A4C7 ligand the amine component is 1-
pyrenemethylamine hydrochloride (A4), the carboxylic acid is phenylacetic acid (C7), 
the aldehyde is the already functionalized glutaraldehyde and the isocyanide is 
isopropyl isocyanide. So in order to perform the Ugi reaction and synthesize the ligand 
the Ugi-components had to be prepared: for A4 solution preparation, 9.4 or 14 mg A4 
were mingled with 2,5 mL 100%(v/v) methanol and 35.26 or 52.8 µl of 1M NaOH for 
neutralization; for C7 preparation, 4.8 or 7.20 mg C7 were mixed with 2.5 mL 
100%(v/v) methanol (all referred quantities are per monolith and depending on type of 
monolith: native or magnetic, respectively). Afterwards, each ready and washed 
monolith containing the aldehyde component on its surface (2.2.6.2.) was placed into a 
30 mL flask and then 5 mL of 100%(v/v) methanol and 2.5 mL A4 were pipetted into 
the flask for a 2 hours reaction to go on (60°C, 220 rpm) with another C=N bond 
formation. The following added compound was isopropyl isocyanide (3.33 or 3.66 µl 
per native or magnetic monolith, respectively), along with 2.5 mL C7 and 5 mL 
100%(v/v) methanol and the reaction was protracted for 48 hours (60°C, 200 rpm).  
Each compound used presented a 5 molar excess in respect to average amine 
content on monolith surface. 
After reaction conclusion each monolith was washed with the following 
solutions (at room temperature, 170 rpm, 10 minutes with each solution): first 
100%(v/v) methanol followed by 50%(v/v) DMF in methanol, destilled H2O, 0.1M HCl, 
H2O again, 0.2M NaOH in 50%(v/v) isopropanol, again 2x H2O and finally 20%(v/v) 
ethanol. 
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Figure 2.5. – Plasma amination79 followed by Ugi reaction onto monolith. “X” denotes oxygen, 
nitrogen or carbon atoms.  
 
 
2.2.6.3.1.  Presence of A4C7 on Functionalized Monoliths Accessed by Fluorescence 
Microscopy 
 
In order to verify the presence of A4C7 ligand on the monolith surface, samples 
of regenerated functionalized monoliths were crushed, placed on a microscope blade, 
moistured with distilled water and covered with a lamella. Then the samples were 
analysed by fluorescence microscopy (40x amplification). Three different photographs 
of the samples field were taken under bright field and filtered light appropriate for 
excitation and emission (λexcitation=460-490 nm and λemission =520 IF), and recorded with 
Cell F software. The negative control was performed with a totally non-functionalized 
monolith either with or without MNPs modification. 
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2.2.7. Screening Assays with GFP and Ligand Leaching Tests 
 
 
Each screening assay encompassed regeneration, equilibration, loading, 
washing and an elution stages performed with the monolith functionalized with A4C7 
in column. The regeneration was carried out by first adding 2x 1 mL distilled water 
followed by 1 mL regenerated buffer (0.1M NaOH, 30%(v/v) isopropanol) alternated 
with 1 mL of distilled water in a total of 2x; regeneration is finalized with 2x 1 mL 
distilled water. Then 5x 1 mL of elution buffer (0.1M Glycine-NaOH pH9 or 0.1M 
Glycine-NaOH pH9 in 50%(v/v) ethyleneglycol) were added  and finally equilibration 
stage was conducted by adding 6 x equilibration buffer (PBS buffer (2.2.5.6.5.)). Each 1 
mL added to the column was collected and 200 µl aliquots were tested for ligand and 
MNPs leaching (2.2.1.1.2.). The later only in case of MNPs modified monoliths. In case 
of ligand leaching the fluorescence was measured with ʎexcitation=485 nm and ʎemission=535 
nm and a gain of 62. Once ready to load, the crude extract produced and containing 
GFP target was added to the column. Incubation times of 0, 15 and 60 minutes were 
tested at 4°C except 0 minutes (tested at room temperature), however all collected 
samples were immediately plunged into ice and covered in aluminium foil. The flow-
through was collected as well as the following 8 washes with PBS buffer and 5 elutions 
(with one or the other of the two referred elution conditions). After the screening all 
columns were regenerated with alternating volumes (1 mL) of regeneration buffer and 
distilled water (3x) finalized with 3 additions of 1 mL of 20%(v/v) ethanol. Monoliths 
were stored at 4°C embedded on PBS. Once more, all fractions were collected and 200 
µl samples were quantified by the BCA assay (2.2.5.6.6.) and GFP fluorescence 
(2.2.5.6.4.). The enrichment of the target by the lead ligand A4C7 was also evaluated by 
SDS-PAGE analysis. 
All stages were carried out under gravitational force excluding the regeneration 
one and the volume added at each step of a stage was 1 mL. Negative controls with  
plain monoliths passed through the same steps and analysis.  
 
 
2.2.7.1.   SDS-PAGE Analysis 
 
 
The presence and enrichment of the GFP was evaluated by SDS-PAGE analysis 
according to 2.2.5.6.3. in which the gel concentration as well as samples preparation 
procedure was maintained, although volume pipetted from each aliquot collected and 
sample buffer were 10 µl and 5 µl, respectively, and 2.5 µl of the protein marker used. 
The gel runned for 75 minutes (130V, 250 mA). The samples analysed were the flow-
through, the two first washes and the first elution. Gels staining were performed with 
 Experimental 
 
41 
 
Silver Stain Plus Kit. The fixative step was conducted by immersing the gel into 200 mL 
fixative enhancer solution (100 mL 100%(v/v) methanol, 20 mL 100%(v/v) glacial acetic 
acid, 20 mL fixative enhancer concentrated solution and 60 mL distilled water) for 20 
minutes under gentle unrest. The solution was discarded and gels 2x cleaned with 200 
mL of distilled water during 10 minutes under mild turmoil. Rinsing water was 
disposed. Then the gels were immersed in a staining solution (distilled water (35 mL), 
silver complex solution (5 mL), reduction moderator solution (5 mL), image 
development reagent (5 mL) and room temperature development accelerator solution 
(50 mL)) and were kept during 20 minutes under gentle unrest to be revealed. When 
the gels were ready, the staining reaction was stopped by adding 5%(v/v) acetic acid 
solution, followed by gently agitation (15 minutes). Finally, the gels were rinsed with 
100 mL MiliQ water (5 minutes) and photographed. 
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3.1.  Introduction 
 
 
The global biopharmaceutical market is an on growing market expected to 
worth 185.7 billion Euros in 2017105. From the three main relevant segments in which 
biopharmaceuticals can be divided (therapeutic proteins, monoclonal antibodies and 
vaccines), therapeutic proteins are the section forecasted to present the highest market 
share (83.6 billion Euros), followed by monoclonal antibodies (MAbs) and finally by 
vaccines (36.1 billion Euros) with the second higher growth rate106. In fact, vaccines are 
the second segment with more products in Phase I and II clinical trials after MAbs, 
covering approximately the same number of products on Phase III as the latter, and 
covering even more products under review by FDA107. The majority of commercialized 
vaccines are viral-based vaccines108.   
Gene-therapy is another on-growing area, where viral particles are the key 
elements. The approval of first drug109 set the beginning of a relevant and expected 
growth109,110, mainly due to this area immense growth potential110,111 and number of 
drugs in clinical trials or awaiting approval109,111. Adenoviruses (Ad) are the preferred 
platform for gene therapy111, and a very attractive choice in vaccination112. Furthermore 
a rise on R&D concerning adenovirus vaccines has experienced a significant growth in 
last decade108. The vogue of Ad as extremely appealing platforms is explained by its 
production in high titers (1010 pfu/mL), capacity to embrace an insert up to 37kb, and 
non-integration into host cell genome, etc.113,114,111. Moreover further developments on 
Ad vectors as gene delivery vehicles allowed significant progress on issues as long-
term transgenes expression and immunogenicity113, rendering Ad even more attractive.    
Ad are 2x108 Da non-enveloped virus, composed by 26-45kb linear double-
stranded genomic DNA protected by a capsid. With a 60–110 nm diameter and an 
icosahedral architecture, its proteic capsid comprises 240 hexon capsomeres covering 
the 20 triangular faces of the icosahedron, and 12 vertex penton capsomeres provided 
with one/two protruding spike-shaped fibers (Figure 3.1.)114,113,115. The hexon capsomer 
protein is a homotrimer of polypeptide II and the penton protein is a pentameric 
structure composed by polypeptide III that together with polypeptide IV trimers 
composes the penton complex. Fiber protein binds non-covalently to penton base 
through its N-terminal tail, and is connected to cell recognizable globular knob domain 
by a rigid rod114. Referred proteins assemble into capsid proteins however, inside 
protein shell coexist minor proteins connected with capsid, and core proteins 
associated to viral genome. At virion core there is also a key protease playing a vital 
role in viral particle assembly. Core proteins are involved in genome replication and 
packaging, whereas minor proteins are involved in maturation, stability, assembly of 
capsid proteins116,117,114.   
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As the charge of each major capsid protein monomer (hexon) in Ad5 is −23.8, 
the capsid is endowed of highly negativity, its overall surface charge exceeds −17,000114. 
 
 
 
 
              
Figure 3.1. – Adenoviral particle external (A) and internal (B) structure. Structures based on 
Martín118 and Russel116 works respectively. 
 
The blockbuster development of virus-based biopharmaceutical drugs for its 
application on vaccination and gene therapy areas demands for: fast-tracking and 
fairly efficient purification; conservation of virus infectivity; great recovery of 
infectious particles; and contaminating DNA and host cell proteins clearance, allowing 
at the same time viral product concentration for minimization of validation 
requirements and final delivery119. Clinical-grade Ad-based vectors, sometimes 
demanded to achieve 1013 total particles/patient or 1011 infectious particles/patient 
claims for robust production and purification protocols at a large scale meeting 
regulatory pharmaceutical requirements compliant with clinical specifications - current 
Good Manufacturing Practices (cGMPs)120. Great quality analytics applied throughout 
upstream and downstream processes to monitor protocol employed are the key to 
guarantee desired final product properties121.  
The traditional methods for adenovirus purification are listed in Table 3.1. CsCl 
method is the most applied one due to its simplicity with extremely pure yields of Ad 
preparations. However the method is limited to small-scale viral lots and CsCl toxicity 
renders imperative the extensive dialysis of Ad preparations. Moreover it presents 
A 
B 
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a 
Precipitation methods are mainly used for recovery of viral particles present in cell-culture medium, and which are 
frequently discarded (~47% of total virus amount). It constitutes an alternative path to CsCl method to be used together 
with it; a Scheme is outlined by Schagen et al.
125
  
 
variable quality of viral preparations, substantial loss of infectivity and aggregation 
during storage115. The tendency however is to design more complex purification 
schemes composed of several steps, and based on chromatography (Figure 3.2.). 
 
 
Table 3.1. – Traditional methods used in Ad purification. 
Purification Steps Target Purity(%) 
VP/IU 
ratio 
Recovery 
(%) 
Ref 
CsCl density gradient ultra-centrifugation rAd5  High 23:1, 8:1 - 122,123 
Sucrose gradient ultra-centrifugation rAd5 
CsCl 
Comparable 
- - 124 
PEG precipitationa rAd5  - 6:1 90 125 
Ammonium sulphate precipitationa rAd5 - 17:1 84 125 
Two-phase Extraction (PEG-salt) rAd5 High n.a. 80 126 
 
 
 
 
In a primary isolation, cells are harvested generally by centrifugation or 
microfiltration, and afterwards Ad particles are separated from cells together with 
most abundant impurities (cell debris, proteins, DNA and metabolites, media 
components and liquid) through cell lysis by chemical, mechanic or thermal means, 
followed, generally, by solid-liquid separation. The cleared lysate is then typically 
digested with nucleases towards minimization of cellular DNA and RNA cargo. This 
step improves product purity (safer viral product), and decreases Ad particles 
agglomeration. Alternatively selective precipitation of cellular DNA can be achieved 
during lysis with cationic detergents reducing or even eliminating DNA removal steps, 
like nuclease treatment or anion exchange chromatography. The nucleic acids-free Ad 
particles solution is then typically filtered, concentrated, and conditioned for 
subsequent final purification114. Concentration of Ad guarantees high titer viral stocks 
decreasing the handling volume, and reducing the number of steps119. During 
intermediate purification a solvent/detergent step should be pertinent to guarantee 
inactivation of enveloped viruses that might have been co-amplified. Final purification, 
where recalcitrant impurities are removed, comprises a capture step, and is usually 
performed by a combination of liquid chromatography and filtration steps. Countless 
chromatography-based methodologies have been reported, exploring properties as 
size, charge, hydrophobicity, and metal affinity; however anion exchange 
chromatography (AEC) is the most popular approach119,114,115.   
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Figure 3.2. – General scheme for Ad downstream purification. Black spheres represent possible 
applicable unit operations (most common ones); numbering represents sequential steps (most 
common ones. The diagram was based on Prazeres work114. On capture step AEC is the only 
method present once it is the most commonly applied one, however Ad can also be separated 
based on size, hydrophobicity, and metal affinity. AEC: anion-exchange chromatography; SEC: 
size exclusion chromatography; IPRPC: ion-pair reversed phase chromatography; IMAC: 
immobilized-metal affinity chromatography.  
 
 
AEC alone seems to be insufficient to guarantee an Ad-based product with the 
demanded purity, so a chromatographic polishing step is required. Afterwards 
product is concentrated, formulated and subjected to sterile filtration. It is noteworthy 
that different chromatographic modes combinations have been applied over time in 
 Development of Monoliths for Viral Particles Purification 
 
49 
 
order to capture and polish Ad particles (Table 3.2.). Monoliths are now being also 
employed. 
Most chromatographic matrices used on virus purification are bead-based, 
however they comprise pore dimensions known to exclude viral vectors, and 
diameters known to limit viral adsorption due to low binding capacities. This issue can 
be addressed by using membrane adsorbers or monolithic columns as tentacle 
supports, once diffusion limitations are surpassed with faster volumetric throughput 
rates and an increment in speed and productivity. However, membranes flow 
aberrations creates shear forces that can compromise performance and productivity of 
labile Ad products, not an issue for monolith platform120,127.  
This chapter aimed at the development of a porous cryogel structure able to 
capture Ad particles from a pre-clarified crude extract, with potential to fulfil all 
virus purification process requirements. This support will be prepared in accordance 
with green chemistry principles.  
 
 
General Conclusions And Recommendations For Future Work 
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Chromatographic 
Steps 
Column type Ligand 
Column 
material 
Pore Size (nm) Target Scale Surface Area 
Flow Rate 
(mL/min) 
Capacity Purity VPe Yield IUf Yield 
VP/IU 
ratio 
Ref 
1. AEC a 
Fractogel 
DEAE-650M 
DEAE 
Methacrylate-
based 
> 80 
rAd5 
1014 VP 
input 
n.a. 2 cm/min 
5.0x1012 
vp/ mL 
High 73% 75% 3:1 
128 
2. IPRPC b PolyFlo n.a. d n.a. n.a. n.a. 2 cm/min 
1.0x1013 
VP/g 
High 84% 94% n.a. 
Final product 
       
>CsCl 55% 57% 1:1 
1. AEC 
Streamline Q 
XL 
Q 
6% Agarose, 
quartz core, 
dextran 
extender 
n.a. 
rAd5 
1012 input of 
VP (2L 
bioreactor 
bulk) 
n.a. 20 n.a. 
CsCl 
Comparable 
70% 45% 13:1 
123 
Final Product 
       
CsCl 
Comparable 
n.a. 32% n.a. 
1. AEC 
Q Sepharose 
XL 
Q 
6% Agarose 
with dextran 
12 
rAd5 
30 mL scale 
suspension 
culture 
n.a. 1.0;4.0 n.a. 96% <~87% (98%) n.a. 
129 2. IMAC c 
Sartobind 
IDA75 
IDA-Zn2+ Cellulose >3000 
75 cm2/2.1 
mL 
1.0;4.0 n.a. 97.20% ~87% 
2.5 x108 
IU/mL 
n.a. 
Final Product 
       
CsCl 
Comparable 
n.a. n.a. n.a. 
1. AEC CIM QA Q 
poly(GMA-co- 
EGDMA) 
1000-5000 rAd5 n.a. ~40 m2/g 3.0 
3x1012 
VP/mL 
High (≥CsCl) 
57.9% 
(can be 
>90%) 
66.70% n.a. 130,131 
Final Product 
         
n.a. n.a. n.a. n.a. 
1. HIC 
Fractogel 
EMD propyl 
(S) 
Propyl 
Methacrylate 
based 
> 80 
rCAV2 1011 pp g 
n.a. 0.5 
0.45 x1012 
vg/mL 
High 88% n.a. n.a. 
132 
2. AEC CIM DEAE DEAE 
poly(GMA-co- 
EDMA) 
600 - 750 ~40 m2/g 2.0 
0.7x1012 
vge/mL 
High 58-69% n.a. n.a. 
Final Product 
       
High 38–45% n.a. 16:1 
Table 3.2.- Summary of possible combinations of chromatographic steps in Ad purification steps. Monolith-based virus separation is starting to emerge. 
a) Anion-exchange chromatography; b) Ion-paired reversed-phase chromatography; c) Immobilized methal affinity chromatography; d) n.a. data no available on the literature as far as we are concerned; e) VP viral particles;  
f) IU infective units; g)Physical particles e) viral genome copy number 
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3.2. Preparation of Monoliths by Freeze-Drying  
 
 
Porous supports for virus separation must possess a robust character, fast flow 
rates and resistance to leachables, but also should have an easy-to-validate direct flow 
use, should involve a low infective titer reduction allied to high recovery yields, should 
be scalable, and comprise a low protein binding with efficient contaminant removal, 
always meeting regulatory standards for safety133–135. These requirements can be 
assured by proper hydrophilicity of the support, chemical and mechanical resistance, 
narrow pore size distribution, and enough reactive surface area, as well as proper 
porosity, interconnectivity, and morphology: stationary phase features that play crucial 
roles in bioseparation procedures27,17,5,136. Freeze-drying, also known as lyophilization, 
has already been employed in the preparation of monoliths27,137,136. Prior to 
lyophilization the homogenized casting solutions were cooled to 0°C and then 
polymerized and/or netted, by addition of the initiator APS and catalyst TEMED (a 
redox pair), in a process named cryopolymerization49,138. Cryogelation that can or not 
involve cryopolymerization relies on the generation of a polymeric structure in a semi-
frozen system (Figure 3.3.). 
The time the polymerizing solution is exposed to the 0°C environment during 
monolith preparation is not enough to form robust and completely nucleated 
crystals139. Indeed as studied by Wilson et al.140 the presence of solute species in an 
aqueous solution is responsible for a nucleation temperature decrease (below -2°C139). 
This decreasing does not depend on the ionic specimen but on its concentration in 
solution139,140. So, the low concentration of casting solutions used in this work is 
thought to have little impact on nucleation temperature, i.e. -2°C. 
This reticulation 0°C period, provided with slow agitation was directed to: 
guarantee maximum spread possible of initiator/catalyst pair, avoiding disruption of 
newly forming net and ensuring later creation of a homogeneous structure, and 
guarantee following solution stabilization, with time and temperature decrease until 
0°C. Moreover freezing driving force of castings transferred from a 0°C environment to 
respective freezer (-20°C/-80°C) is less pronounced than from a room temperature 
environment. This allows a better organization of the system in: polymeric structure 
and ice crystal lattices141. 
After this initial phase, cryogelation continues at negative temperatures (-20°C 
and/or -80°C depending on the desired monolithic specimen), where growth of crystals 
takes place.  
 
Apart from the freezing temperature applied or composites nature, it is known 
that in both cases a nucleation phenomenon starts, immediately followed by crystal 
growth. Indeed there is a competition between these two phenomena, which 
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determines the features of originated crystals. That is, if one is in presence of a rapid 
freezing (in this case -80°C) several nuclei will be formed, and the time for growth is 
minimal; this lead to the formation of countless small ice crystals. On the other hand, if 
one is in presence of a slow freezing (in this case -20°C), it will be formed a smaller 
amount of crystals, but with higher dimensions139,140,27. Actually it is these fast and slow 
freezing phenomena (different rates of crystal growth) that were used in this work to 
tune crystal dimensions, and so monolith microstructure, once the crystals define each 
pore dimensions and shape. Indeed further sublimation of ice then empties the pores 
leading to different macroporous structures, depending on the freezing temperature 
applied. Moreover it is this 3D microstructure that will define the properties of the 
monoliths prepared and so its applicability in the desired area. 
 
 
 
Figure 3.3. – Cryogelation process: The initial system comprising a reaction mixture rich on gel-
forming units is frozen; despite looking as a whole firm block, the system is essentially 
heterogeneous containing an unfrozen liquid micro-phase (UFLMP) together with crystals of 
frozen solvent; the gel-forming units concentrated in UFLMP allows cryo-concentration 
occurance with gel formation; solvent acts as porogen leaving cavities when sublimated; the 
surface tension between solvent and gel phase guarantees the round smooth shape of pores. 
Green ribbons represent polymers, blue dots represent solvent molecules and the red ones 
represent the low-molecular weight solutes (e.g. monomers, initiators). Schem based on142,143.   
 
  
Thus it can be stated that freezing is a determinant step in the preparation of 
porous structures with controllable pore morphologies, making freeze-drying a 
technique that creates tunable porogenic ice templates that left interconnected pores 
when water is sublimated.  
A 
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The temperatures and time of freezing was proven to be applicable and 
adequate for all casting solutions, once -20°C and -80°C temperatures are located below 
literature reported temperatures, ensuring adequate casting freezing9,27. This is 
corroborated by qualitative and quantitative characterization of prepared monoliths.  
In respect to the average time any solution may remain at subzero 
temperatures, it is defined by the degree of supercooling and heterogeneous nucleation 
sites available140,139. The 24h of cryotropic conditions time seemed to be enough due to 
macro and microscopic morphology of materials upon monolith sectioning (Figure 
3.4.). 
Finally the sublimation of water solvent under vacuum and at approximately -
45°C allowed the formation of macroporous structures (Figure 3.3.) with in principle 
highly interconnected pore channels: ice crystals, acting as in situ porogens growing 
next to each other until they meet at a certain point the sides of other crystals, lead to a 
more or less robust ice scaffold structure that disappears during sublimation, and 
leaves a system of interconnected pores inside the cryogel144. In fact the casting 
solutions concentrations of minimum 2% and maximum 6.7% enhances this effect 
contributing to produce a highly interconnected open pore 3D structure (water vol.% is 
a tuning parameter)145,144.  
 
 
    
 
 
 
 
 
 
 
 
 
 
Figure 3.4. - Whole dextran-based monolith (A) and the three samples in which it was sliced (B).  
 
 
 
 
 
 
 
 
A
10 mm 
B B 
10 mm 
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3.3. Monoliths Architecture and Analysis of its 
Properties through Characterization 
 
 
3.3.1.  Materials Employed: an Overview 
 
 
In order to elect the most promising monoliths for the mentioned application it 
was imperative the accomplishment of a series of measurements. In fact the screening 
of the various proposed materials was made through stability tests, porosity and water 
flux measurements, and finally macro-scale mechanical compression experiments at 
dry and hydrated state. Those analyses were made in order to select the three most 
promising monolithic candidates, from a total of twenty three prepared from some 
initially elected potential materials. 
The prospective bulk materials include the natural polymers chitosan, dextran 
and agarose (Figure 3.5.).  
 
 
 
Figure 3.5. – Polymers (blue) and monomers (orange) used in monoliths preparation towards a 
novel, green and virus purifying support.  
 
 
Through the usage of these natural materials, monoliths prepared assured a 
highly hydrophilic surface, not only crucial for the allowance of a reversible 
adsorption, a requirement in bioseparation processes, but also allowance of low protein 
adsoption and provision of low unspecific binding. The richness of hydroxyl groups on 
MBAAm AAm 
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the surface of prepared monoliths is the responsible for this character, also allowing for 
the availability of enough functional groups where ligands can be inserted for specific 
modifications of that surface146,147. To the mentioned advantages joins the 
biodegradability, biocompatibility, ready availability and inexpensive ease of 
processing. Thus countless advantages led to the election of natural polymers as bulk 
materials. To the stated benefits joins the commercial availability or lab developing of 
monoliths mainly based on silica, acrylamide or methacrylates6,3,19; and the series of 
commercial products for chromatographic applications that are already based on 
modified natural polymers. This situation makes it easier for the market to accept 
natural-monoliths147.  
However, hydrophilic natural-polymers originate soft structures with poor 
mechanical properties for chromatography purposes4. For that reason, and in order to 
thwart this reality, it was decided to add a crosslinker agent (e.g. MBAAm) to the 
casting, or even blend it with synthetic polymers and monomers like poly(vinyl 
alcohol), acrylamide and/or glycidyl methacrylate. One problem that accompanies this 
pathway is the increasing in the hydrophobicity of the support as well as the non-
specific adsorption. This reinforces why, after this monoliths screening, the elected 
supports have to be tested without any chemical modification on its surface towards 
the target; allowing the inspection for this non-specific adsorption of virus and also 
host cell proteins, once the work goal is the purification of virus with maximum 
recovery, titer concentration and purity. Beyond helping on the achievement of 
pretended mechanical and swelling properties, chemical crosslinking of polymers, 
generally, translates itself on a reduction in degradation rate (covalent bonds and 
entanglements between polymer chains give rise to a more enclosed hindered network 
structure, more difficult to disrupt)148. 
According to the literature either the crosslinker or the monomers used in PVA 
and chitosan, agarose and dextran-based monoliths (i.e. MBAAm or AAm, GMA, 
respectively) unlikely form covalent bonds with the stated polymers at the reaction 
conditions employed (cryo-conditions in presence of APS/TEMED)149,150. Instead they 
probably polymerize and imprison the polymeric chains in certain points (e.g. chitosan, 
C/P, C-G and P-G monoliths (Table 3.3.)), i.e. probably when the monomers/crosslinker 
are present in very low quantities; or entangle and imprison globally the polymer 
chains (e.g. agarose and dextran-based monoliths). This probably happens once a free 
radical polymerization reaction generally ends when two polymerizing ends find each 
other151. The later scenario takes place generally when monomers quantity is 
significative towards polymer. See Figure 3.6..  
An interpenetrating polymer network (IPN) can be defined as a blend of two or 
more linear or branched polymers in a network structure, in which no less than one is 
synthesized and/or crosslinked in the immediate attendance of the other(s); moreover 
the networks are at least partially entangled, however not covalently bonded to each 
other, thus leading to the impossibility of separation of the networks without breaking 
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chemical bonds152,153. On the other hand, while a full-IPN comprises only crosslinked 
chains independent from each other but entangled in each other, the other type of IPN, 
semi-IPN, corresponds to a non-reacting polymer entrapped by a crosslinked polymer 
or co-polymer network entangled in the polymer153. This leads to the conclusion that in 
case of P-G and C-G structures they constitute a semi-IPN, once the structures seems to 
be similar to Jain et al. ones149. In case of agarose and dextran, once there is no 
crosslinking, just an entangling synthesized copolymer that closes upon itself 
imprisoning the base polymer, it should probably be included into the IPN category. 
Indeed no covalent binding is likely to occur between polymer backbone and 
crosslinker molecule, only polymerization of crosslinker. 
 
 
Table 3.3. – Monoliths prepared for screening tests accompanied by the respective 
monomeric/polymeric ratios. 
Materials 
Proportions 
%(w/w) 
Concentrations 
%(w/w) 
Freezing 
Temperature 
(°C) 
Monolith 
Denomination 
Chitosan 100 
2.9 -20 and -80 C2.9% 
2.0 -20 and -80 C2% 
Chitosan/Polyvinyl Alcohol 
50:50 
2.9 
-20 and -80 C/P(50:50) 
33:67 -20 and -80 C/P(33:67) 
Chitosan-Glycidyl methacrylate 89:11 2.9 -20 and -80 C-G 
Polyvinyl Alcohol-Glycidyl methacrylate 
79:21 3.3 -20 and -80 P-G(79:21) 
89:11 2.9 -20 and -80 P-G(89:11) 
Acrylamide-N,N'-
Methylenebisacrylamide*-Glycidyl 
methacrylate 
78:17:5 
3.1 -20 AAm-MBAAm3.1% 
6.5 -20 AAm-MBAAm6.5% 
Agarose- Acrylamide - Glycidyl 
methacrylate 
56:7:37 4.5 -20 A-AAm-G(56:7:37) 
58:12:30 5.4 -20 A-AAm-G(58:12:30) 
Dextran-Acrylamide-Glycidyl 
methacrylate 
56:7:37 
4.5 
-20 and -80 D-AAm-G(56:7:37) 
49:14:37 -80 D-AAm-G(49:14:37) 
58:12:30 
5.4 
-20 and -80 D-AAm-G(58:12:30) 
52:17:30 -80 D-AAm-G(52:17:30) 
Polyvinyl Alcohol 100 2.9 -20 and -80 P100% 
 
 
 
 
The preparation of monoliths using as only composites GMA and the 
hydrophilic monomers acrylamide, MBAAm to give form to a natural-polymer non-
based monolith seems to be a pertinent choice, due to the macropores such a structure 
can be composed of (≤105 nm), and the possibility of comparison towards natural 
monoliths9,154. This structure should comprise a closed network of copolymers, once all 
monomers covalently bind to each other and the two reactive ends of MBAAM 
molecule guarantee crosslinking between chains. 
* N,N'-Methylenebisacrylamide (MBAAm) is used not only as a crosslinker but also as a monomer. 
“/” denotes a blend 
“-“ denotes a copolymerization 
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Hydrophilic poly(vinyl alcohol) was blended with the hydrophobic glycidyl 
methacrylate, once the produced structure is thought to have a reasonable hydrophilic 
character with uniform pores. The monolith prepared is a semi-IPN, once PVA is 
probably interpenetrated by the polymerizing GMA monomers (crosslinked by 
MBAAm) that form a polymeric network of poly(GMA) entangling and imprisoning 
PVA. This weak chemical character of the structure renders unnecessary the chemical 
crosslinking of PVA with the so used cytotoxic glutaraldehyde, which implies non-
uniformity of the obtained matrix155. The pure and sole physical crosslinking (only H-
bonging, Van der Walls, coulombic, dipole–dipole, hydrophobic interactions or 
crystallites156) can also be avoided. 
 
 
 
Figure 3.6. – Polymer scale arrangement of composites into monoliths. Structure of chitosan 
blended with PVA monolith (C/P) (A). Hydrogen bonds are established between polymer 
chains; and MBAAm polymerizes and imprisons the H-bonding stabilized chains improving. 
Structure of semi-IPN C-G monolith (B). Here MBAAm crosslinks poly-GMA imprisoning 
chitosan at some regions. Structure of agarose and dextran-based monoliths (C) where the 
closed (no loose ends) AAm-GMA copolymer entangles and imprisons agarose/dextran. Orange 
ribbon represents chitosan; blue ribbon represents PVA molecule; black piece represents 
MBAAm monomer; black ribbon represents polymerized MBAAm imprisoning H-bonding 
stabilized C/P chains; green shadow highlights the H-bonding. Purple chains represent poly-
GMA; brown sticks represents intra-chain covalent bonds. Pink chain represents 
agarose/dextran; green chain represents poly(AAm-GMA) chains. 
 
 
Actually this type of crosslinking is biologically advantageous, once no toxicity 
is granted to the final monolith due to the presence of moieties potentially obliterators 
A B 
C Loose End 
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of biocompatibility157,155.  They can be achieved through repetitive freeze-thaw cycles in 
aqueous solution, in which crystalline clusters are created functioning as junction 
zones, or complex coacervation (ionic interactions), etc.158,155. However, although the 
formed cryogels present stability at room temperature for even months, these type of 
crosslinks alone159 present poorer mechanical and thermal stability when compared 
with the chemical crosslinks158. The annexation of polymerizable functionalities onto 
the polymer backbone is also a way to avoid the utilization of crosslinkers, as the 
addition of unsaturations enables the reticulation of modified polymer chains. GMA 
was reported to be widespread utilized for the addition of methacryloyl groups on 
PVA backbone through a transesterification reaction in DMSO155,160,161.  
Indeed it is noteworthy that it is broadly reported in the literature the 
utilization of both PVA and GMA together, however only for PVA modification. This 
could be performed as an alternative to the prepared P-G monolith of this work. 
However that modification of PVA can be thought to imply a slightly more 
hydrophobic character to final monolith, due to the loss of glycidol group and 
consequent decrease on oxygen atoms in comparison to poly(GMA) formation162,163. 
Moreover as the purpose of this research work is the pursuit of a green and sustainable 
support the utilization of organic solvents is a way to be as much as possible avoided. 
Furthermore poly(vinyl alcohol) chemical resistance, physical properties, 
biocompatibility, water solubility, biodegradability and low cost are very attractive 
stimulating the preparation of monoliths including this synthetic polymer164,27. That is 
why it was blended with chitosan.  
Chitosan is a cationic polymer resultant from alkaline deacetylation or 
enzymatic degradation of chitin (after cellulose the most abundant polysaccharide)6. 
With a backbone comprising β(1→4)-glucosamine and N-acetyl-D-glucosamine 
residues in different relative proportions, it has proven to be biologically renewable, 
antimicrobial, biodegradable, biocompatible, non-antigenic, non-toxic, biofunctional, 
and sensitive towards changes in pH.. Mechanical properties of chitosan-based 
materials have also been an engine for the interest in its usage165,27,137. Chitosan was also 
copolymerized with GMA forming a semi-IPN structure. In fact by combining 
synthetic and natural polymers in either IPN or semi-IPN systems, both support 
physical and biocompatibility properties can be enhanced155. 
Agarose, an algal polysaccharide have been selected due to its high chemical 
stability over a wide pH and temperature range, hydrophilicity conducting to a 
significant low non-specific binding of countless proteins and biological molecules, 
good biocompatibility, and low toxicity, properties responsible for its popularity as a 
constitutive material on purification/separation supports. Its low mechanical stability 
limits its usage at relatively high flow rates on HPLC, however with an attractive 
gravitational flow no pressurized systems need to be used8. 
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Regarding dextran it is a water-soluble bacterial exopolysacharide composed 
mostly by α-1,6-linked D-glucopyranose units and known for its good water-solubility, 
environmental safety, non-toxicity, bioavailability and high biocompatibility165. 
 
 
3.3.2. Monoliths Characterization 
 
Once any proposed monolith is going to be applied under hydrated conditions 
all the studies performed at this state are deeply crucial and very enlightening. The 
working pH range is not certain so, and also to test the biodegradability of the 
supports, monolith rods were placed at different pHs and studied for two weeks. 
Despite their distinction through classification standards they all origins hydrogels, so 
all samples presented swelling properties with a significant water uptake156. Indeed 
“reticulation degree” seemed sufficiently high once, in general, all polymeric matrices 
were verified to be insoluble in water (though swellable in it)166. Monoliths that 
qualitatively presented more water uptake capacity were C2.9%, C3% and dextran-
based monoliths, independently from the preparation temperature. This is a good hint 
once the more water uptake capacity the more virus containing cellular crude extract 
can access the binding sites on the support. However dextran monoliths disintegrated 
after three days (prepared at -20°C) or five days (prepared at -80°C) at all pHs (Table 
3.4.).  
 
Table 3.4.– Stability Tests performed at pH3, 7 and 11 with different monoliths prepared at -
20°C/-80°C. Monoliths were macroscopically analysed during fourteen days. 
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P-G monoliths frozen at -20 °C also had the same behaviour, except P-G(79:21)-
80. Indeed this behaviourism lead to a 15 minutes enlargement of the reticulation time 
of first prepared dextran-based monoliths, in order to allow a better 
arrangement/stabilization of composites before freezing and see if the problem was 
caused by reaction time. Thus according to the results (easy disintegration upon 
tweezers mechanical disturbance) the time extension seemed to be insignificant. 
However the reduction on freezing temperature from -20°C to -80°C seemed more 
appropriate. However the soft structures achieved were considered not suitable for the 
purpose of the work (same was valid for P-G monoliths). 
The remaining supports frozen at both temperatures were stable.  Some 
photographs of the progressive behaviour of chitosan-based monoliths are pictured at 
Table 3.5..  
All monoliths developed in this work, besides being cryogels – macroporous 
structures with interconnected pores ranging from several to hundreds of micrometers, 
allowing easy permeability for biomacromolecules49 – they also constitute hydrogels. 
These structures, can be classified into chemical or physical gels, if the chains are hold 
together by covalent  bonds, or otherwise by  hydrogen bonds, Van der Waals forces or 
physical entanglements, respectively167. Still they can be termed: i) permanent at a 
given set of experimental conditions, if they involve covalent bonds or strong physical 
bonds; ii) reversible, if they involve weak physical interactions formed from temporary 
associations between chains158. 
 
 
Table 3.5.– Stability Tests performed at pH 3, 7 and 11 of different chitosan-based monoliths 
prepared at -20°C. Monoliths behaviour was analysed during fourteen days, having the first 
picture being taken at day three. 
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All structures produced constitute physical gels with a minor chemical 
character, and should be non-permanent once only physical entanglement between 
chains probably takes place. Moreover they all have degradable polymer backbones, 
except AAm-MBAAm monoliths, once polyacrylamide is not biodegradable neither is 
the synthetic small monomer/crosslinker MBAAm, and C-G, due to crosslinking 
between poly(GMA) chains. 
Despite the implementation of a non-degradable crosslinking agent on 
chitosan-based monoliths, its low content in casting solution (5.6%(w/w) with respect 
to the polymers and/or monomers mass) allows the formation of a sufficient open 
mesh that should allow an accelerated chemical degradation. 
The retaining capability of produced hydrogels is possible due to its insolubility 
(provided by the entangled arrangement between chains), and is related to the 
polymer-water interactions or hydrophilic groups amount on the surface of support, 
depending also on the crosslinking density. This leads to retaining capacities ranging 
from ~10% up to thousands of times its dry weight, always maintaining its structure167. 
An increase on hydrophilic groups’ content implies higher water retention by the 
matrix, while an increase on crosslinking density entails a lower swelling equilibrium, 
due to a decrease in the hydrophilicity and reduction in stretchability provided by a 
rise on polymeric mesh constraints. 
Chitosan is a polymer known to have the ability to respond to pH changes in 
surrounding environment by protonation/deprotonation of its amine groups 
(pKa≈6.3)168. Thus chitosan-based monoliths must present changes in their swelling 
ability according to the external environment. The remaining monolith specimens due 
to the absence of ionizable groups in their molecular structures at any pH buffer they 
should not present any structural changes upon pH variation169.  As some chitosan-
based monoliths were copolymerized or blended with other monomers and polymers, 
dynamic swelling assays were performed to access some information about structures 
produced.  
Through Figure 3.7. it can be observed that all chitosan-based monoliths 
prepared at -20°C change its structure for different H+ concentrations in solution. They 
all present slightly swelled structures at pH7 and relaxed, voluminous, highly swelled 
frames at pH5. At low buffer pHs (<pKa of chitosan), like pH5, there is a transfer of H+ 
to the –NH2 groups distributed all over chitosan chains ionizing them to –NH3+. 
According to Donnan theory this results in displacement and accumulation of 
counterions (A-)1 inside the hydrogel, creating an osmotic pressure gradient between 
the inside and outside, forcing water entrance into the system. The positive charges 
generated, also create electrostatic repulsion forces, which contribute to the expansion 
of gel mesh169. However as cryogels swell and matrix enlarges the osmotic pressure 
declines, and elastic retraction forces provided by the imprisoned mesh increases158,169.  
                                                            
1 A- refers to the basic specie from the acid/base solution equilibrium AH↔A+ + H+ 
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Figure 3.7. – Cyclical swelling analysis: variation of percent swelling degree (W) with time (t).  
Each monolith (frozen at -20°C) is alternately plunged into two different pH buffers (pH7 and 5) 
over time.  C2.9% (a); C2% (b); C-G (c) C/P(50:50) (d); C/P(33:67) (e). All samples are presented 
in duplicate. 
 
 
The eventual balance of these two opposing forces is reflected in the plateaus 
observed for all plots, few hours after buffer plunge. When the samples are placed in 
pH7 buffer the originally charged groups of chitosan lose charges losing also their 
attraction for counter-ions. Thus net osmotic pressure difference between inside and 
outside environments decrease and monoliths shrink.  
It can be observed that monoliths swelled very fast (it could be observed even 
with naked eye) reaching its final swollen state in few minutes. Furthermore it can be 
concluded that all chitosan-based monoliths have pH memory once plateau values at 
same pH are approximately the same.   
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Analysing carefully the first swelling plateau at pH7 C2% presents a slightly 
higher equilibrium swelling comparing to C2.9%. Chitosan with its high molecular 
weight chains leads to viscous casting solutions, that will originate smaller crystals, 
smaller pores and thicker walls; thus a reduction on polymer concentration should and 
seems to result in larger pores with thinner struts allowing an easier matrix expand, 
and so higher W(%)27. Moreover the higher amount of imprisoner (MBAAm) in C2% 
limits even more the swelling ability. Regarding C-G, C/P(50:50) and C/P(33:67) all 
present lower and decreasing values comparing to C2.9%; this reflects the reduction on 
the hydrophilic portion (number of ionic groups decreases together with number of 
counter-ions inside the hydrogels, producing a reduced osmotic pressure that confines 
cryogel swelling) by increasingly adding PVA or GMA over only chitosan170,171.  
Conversely at pH5, C2% presents a lower swelling degree (W(%)) than C2.9% 
(2500% against 4000%, respectively). This is probably explained by the higher density 
of imprisoner in C2% monolith against C2.9%. In C2.9% the concentration of polymer 
in solution is 30mg/mL whereas in C2% the concentration was decreased to 20mg/mL, 
but the concentration of imprisoner for both formulations was 1.7mg/mL. The higher 
the crosslinker density, the higher the resistance of the material to volume enlargement 
during water uptake171. In case of chitosan/PVA blends and chitosan copolymerized 
with GMA the W% value is also lower than the one held by C2.9%. Probably what 
occurs is that the network freedom to swell is compromised not only by a decrease on 
ionic groups, but also by an improvement on mechanical properties. This results in an 
increment on elastic contraction forces exerted by the hydrogel towards water 
entrance27,172. Indeed a growing chitosan:PVA ratio seems to result in a more 
constrained swelling. Analysing closely C-G, its equilibrium swelling jump is shorter 
in comparison to the C/P. This is probably explained by the viscoelastic properties of 
PVA173.  
Figure 3.8. plots the swelling dynamics of chitosan-based monoliths prepared at 
-80°C. Looking to the pH5 and 7 both equilibrium swelling plateaus, the results show a 
reduction for all monoliths. This seems to be caused by the smaller sized pores, with 
probably more compact walls (stiffer materials as proved by Table 3.6. versus Table 
3.7.). These compact walls with closer and tighter polymer segments should reduce the 
access of water to bulk material with consequent limitations on swelling behaviour. 
Moreover the distance between crosslinks within the cryogel frame becomes shorter 
constraining the expansion174. Indeed a larger pore architecture has been already 
involved in lower swelling degrees175,176. This reduction on swelling upon freezing 
temperature reduction is a slight one, probably due to the high surface area provided 
by small pores. 
Chitosan 100% cryogels seem to present the highest W(%) and C/P(33:67) the 
lowest, probably because of its higher rigidity due to PVA content. A rise is observed 
in the second pH 5 plateau for C2.9% and C2% reflecting probably the poor elasticity of 
100% natural monolith, stretching forward but not completely back.   
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In both Figures 3.7. and 3.8. it is notorious a general progressive rise on the 
swelling degree. This is possibly explained by the gradual hydration over time, with 
progressive expansion and relaxation of polymer chains. Maybe a cooperative action of 
network relaxation and water diffusion in addition to flow of water through pores174. 
Probably this picture would be different if the study was performed at pH~3 and 9 
instead of pH5 and 7 respectively, where the osmotic pressure gradient would be so 
maximum169. The higher value for the first pH5 plateau on C/P(33:67) prepared at -80°C 
in comparison to its counterpart prepared at -20°C can be related with the higher 
surface area of the monoliths prepared at lower temperatures, a variable that seems to 
surpass all the others154.  
 
 
 
  
 
Figure 3.8. – Variation of percent swelling degree (W) with time (t).  Each monolith (frozen at -
80°C) is alternately plunged into two different pH (pH 7 and 5) solutions over time (t).  C2.9% 
(a); C2% (b); C/P(50:50) (c); C/P(33:67) (d). All samples are presented in duplicate. 
 
According to Table 3.6. all monoliths prepared were, as expected, highly porous 
(≥83%). When composites concentration is raised to 6.5% the porosity seems to be 
approximately maintained (88±4 for AAm-MBAAm3.1% against 83±5 for AAm-
MBAAm6.5%). However comparing these results to the compressive modulus data we 
can detect that Archimedes displacement method was non-sufficiently accurate for 
measuring porosity. Measuring porosity by weighing the mass loss of a certain 
displacement liquid renders the technique restricted by accuracy to weight that mass 
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loss and by displacement liquid chosen. Moreover the volume measurement with a 
ruler increases significantly that inaccuracy. In this work the displacement liquid 
elected was ethanol, once it can enter the pores easily without network swelling or 
shrinkage177. However due to its vapour pressure at 20°C (44.6 mmHg178) maybe 2-
propanol (33 mmHg179) could be an alternative180; other methods could also be 
employed (mercury intrusion porosimetry27,137, physical gas adsorption, inverse size-
exclusion chromatography). Indeed porosity mirrors the stiffness of a material181,27, in 
which a lower void volume fraction should imply a higher resistance to equipment 
claws motion (higher compressive modulus), i.e. a stiffer monolith. Thus a higher 
compressive modulus associated with a lower porosity was expected from AAm-
MBAAm6.5%. The highest compressive modulus of dry and wet AAm-MBAAm6.5% 
against AAm-MBAAm3.1% shows the influence of a closer mesh on the rigidity of the 
matrix. A closer network should result from thicker struts136,174, that in turn should 
accrue from a higher casting concentration, resisting more to the opposing destructive 
force of equipment claws. 
 
 
Table 3.6. – Morphological and mechanical properties of all monoliths prepared at -20°C. All 
data was obtained from duplicated measurements (in case of water flux measurements each one 
of the two samples was measured three times). 
Monolith 
 
T Freezing (°C) 
Porositya 
(%) 
Water Flux 
(L.m-2h-1) 
Compressive Modulus (kPa) 
Dry Hydrated 
C2.9% 
-20 
89±3 79±1 1.5±0.4 0.4±0.1 
C2% 91±2 n.a.b 2.6±0.1 0.6±0.1 
C/P(50:50) 94.6±0.3 151±43  3.8±0.1 0.7±0.3 
C/P(33:67) 93±3 72±24 4.3±1.0 0.2±0.04 
C-G 93±1 209±18 3.7±0.2 1.9±0.1 
A-Am-G(56:7:37) 
-20 
95±1 307±63 1.76±0.05 0.61±0.04 
A-Am-G(58:12:30) 95±1 265±44  5.0±0.1 0.77±0.05 
AAm-MBAAm3.1% 
-20 
88±4 23±11 1.6±0.1 0.6±0.1 
AAm-MBAAm6.5% 83±5 14±8 2.4±0.1 0.7±0.3 
P-G(79:21) 
-20 
91.8±0.3 7±1 1.8±0.1 0.6±0.02 
P-G(89:11) 93±1 14±1 1.2±0.2 0.9±0.2 
D-AAm-G(56:7:37) 
-20 
94.7±0.5 148±48 0.8±0.1 0.25±0.03 
D-AAm-G(58:12:30) 95±2 90±16 0.49±0.05 0.3±0.01 
 
 
 
  Regarding water flux through monoliths it mirrors the effects of main 
architectural properties on mass transportation182; it reflects the combination of five 
important parameters on monoliths: porosity; pore size, shape and distribution; 
interconnectivity; fenestration size and distribution; and orientation of pores183. Thus 
assuming interconnectivity maintenance, the decrease in porosity, and probably pore 
and fenestration size (caused by the thicker struts of increased feed concentration) may 
a Porosity values obtained through Archimedes Principle 
b Value impossible to measure, maybe due  to  wall rupture, as consequence of their thin thickness 
 
 Development of Monoliths For Viral Particles Purification 
 
66 
 
decrease the water flux value183,184, as it can be slightly seen comparing AAm-
MBAAm3.1% and AAm-MBAAm6.5%. The so low global water flux values of AAm-
MBAAm monoliths may be originated by the so closed network comprising them (high 
concentration of crosslinker185), that leads to minor space between network chains 
available to accept the free water, and so they have tendency to be bound to surface 
polymer chains (low hydration). The closed mesh may even jeopardize pore 
interconnectivity136 (small fenestrations or poor connection due to the higher casting 
viscosity) despite the high porosity value183.  Li 2003;Kemppainen 2010; 
In case of P-G monoliths, in P-G(79:21) only GMA content was raised in 
comparison to its resembling P-G(89:11), leading to a higher casting concentration and 
a higher imprisoning polymer concentration (Table 3.3.). Lower porosity and flux as 
well as higher compression modulus were expected and obtained. However as water 
flux is a reflection of countless architectural monolith features, the so low global water 
flux value must be related to the fragile character shown on stability tests, that 
probably conducts to a collapsed structure with an emphasized tortuosity (result of 
preclusion offered to fluid flow by the structure internal architectute186). According to 
information accessed the wet compression modulus may present a high value. It 
should be explained once again by its deformed/sloppy structure that retains the water 
that should be expelled during uniaxial compression; once retained and as it is 
uncompressible the water insert bias on the final values. 
In dextran-based monoliths from D-AAm-G(56:7:37) to D-AAm-G(58:12:30) the 
GMA concentration was maintained constant but dextran and acrylamide 
concentrations were raised in the same proportion. The increase in casting 
concentration (Table 3.3.) should lead to,  as P-G monoliths, a lower porosity, higher 
dry and wet compressive modulus and lower water flux, from D-AAm-G(58:12:30) 
against D-AAm-G(56:7:37). Water flux values were confirmed, however porosity 
values seems unchanged and therefore probably compromised by referred inaccuracy 
of used method. In respect to dry compression modulus the strange value of D-AAm-
G(56:7:37) and D-AAm-G(58:12:30)  could maybe be explained by the increment in the 
less rigid monomer constitutive of the coiling imprisoning copolymer, i.e. acrylamide , 
rendering the increment in concentration not significant in terms of stiffness 
improvement.  
The GMA maintenance with increment in acrylamide and base polymer was 
also accomplished on agarose-based monoliths. Once more porosity seems to be 
maintained between specimens (A-AAm-G(56:7:37), A-AAm-G(58:12:30)) with water 
flux decreasing with increasing concentration. However dry and wet compression 
moduli increase significantly from A-AAm-G(56:7:37) to A-AAm-G(58:12:30). The ~1% 
increment on composites concentration seems to be enough to significantly alter 
monolith properties. Maybe the difference between agarose and dextran-based 
monoliths lies on the natural polymer itself: upon cooling, agarose chains are known to 
form helical fibres that assemble into supercoiled structures with 20-30 nm radii187; and 
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they seem to constitute branch lacking quasi-rigid linear fibers with lengths dependent 
on polymer concentration, explaining the very low concentration need for its gelation 
and the high shear modulus of the gels, in comparison to that of a gel gathered from a 
flexible chain188 (like dextran189). 
    Comparing C2% and C2.9%, the former which has a lower concentration is 
expected to present a lower casting viscosity, consequent larger pore size and thinner 
struts, which imply higher porosity and lower compression modulus. The also 
consequent lower surface area should origin a higher water flux. Porosity and dry 
compressive modulus check. However the same is not true for water flux and wet 
compression modulus, which was probably caused by increased coiling imprisoning 
monomer concentration, whose effect is just noticed at hydrated state, reinforcing 
swelling analyzes. This higher imprisoning monomer concentration reduces the effects 
of higher polymer concentration, and also leads to narrow spaces between the polymer 
chains limiting free water acceptance. Thus water molecules (not free) have tendency 
to bind polymer chains, enhancing resistance to solute diffusion (lower water flux)174.  
The copolymerization of chitosan with GMA or PVA seems, as expected to 
improve chitosan mechanical properties. Against expectations the porosity also 
increased, this maybe happened because the increase in mechanical strength drift from 
the materials themselves and not from the thickening of struts. In fact it should be 
related with a larger pore size caused by a reduction on casting viscosity27; possibly 
also explaining the increased water flux. However for C/P(33:67) despite the higher 
porosity the water flux seemed to even drop. Maybe the problem is the PVA content, 
probably insufficiently hydrophylic to grant the water flux desired for the 
application190. Just decreasing freezing temperature a whole set of new and different 
materials were produced.  
 
Generally speaking, Table 3.7., as well as Table 3.6., shows lower compression 
moduli for wet specimens than for dry ones. This could be explained by the mobility of 
network chains upon hydration. These values are very important once the monolith is 
going to be applied in its hydrated state. However the compression moduli for 
monoliths prepared at -80°C increased. This is probably related to the formation of 
more compacted and rigid materials191.  What could have happened is that the isotropic 
cellular pore morphology, as a result of rapid ice crystals growth, scatters the 
unidirectional pressure in every direction, rendering it more difficult to be damaged 
when compressed. Conversely the anisotropic pore architecture that should 
characterize monoliths prepared at -20°C (due to ice crystals growing along the 
direction of the temperature gradient) should present lower compressive modulus 
once the stress tends to concentrate around the channels of the scaffold with crossed 
fibers raising the risk of destruction191,192.  Indeed this results support swelling 
measurements. 
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Table 3.7. – Morphological and mechanical properties of all monoliths prepared at -80°C. All 
data was obtained from duplicated measurements (in case of water flux measurements each one 
of the two samples was measured three times). 
Monolith TFreezing (°C) Porosity (%) 
Water Flux 
(L.m-2h-1) 
Compressive Modulus (kPa) 
Dry Wet 
C2.9% 
-80 
91±3 69±8 4.1±0.9 1.8±0.3 
C2% 90±3 16±0 1.9±0.5 0.8±0.1 
CP50:50 91.0±0.4 74±21 10.1±1.1 1.7±0.3 
CP33:67 90±4 4±1 10.5±2.3 1.0±0.3 
C-G 91.0±0.3 188±39 6.7±2.2 1.29±0.05 
P/G(79:21) 85±4 15±5 2.6±0.6 n.ab 
P/G(89:11) 83±4 2±1 3.1±1.7 n.a 
D/AmG(56:7:37) 95.5±0.3 3±0 0.60±0.04 n.a 
D/Am-G(49:14:37) 95±3 13±5 1.4±0.5  n.a 
D/Am-G(58:12:30) 89±4 49±12 0.8±0.1 1.0±0.3 
D/Am-G (52:17:30) 96.4±0.4 26±1 1.0±0.2  0.88* 
 
 
 
 
However in cases where porosity lowers, this parameter may help in this 
compression moduli increase. The shorter distance between coiling imprisoning 
fractions maybe also contribute to the higher modulus, once this shortening should 
make the monolith more rigid restricting the relaxation of polymer chains with 
negative influence on water flow174. 
Lowering freezing temperature to -80°C seems, as expected, to have decreased 
the average pore size27, once water flux values are very low in comparison to Table 3.6. 
Assuming maintenance of porosity, the higher surface area produced by the minor 
pore size is known to increase the friction force between fluid and material, hindering 
the water flow183. C-G has not only the higher value from Table 3.7., its value is very 
close from its -20°C resembling. This can be caused by the imprisoning hydrophobic 
polyGMA formed, that somehow facilitates crystal growth. Maybe its presence helps 
not only in the reduction of casting viscosity (that by itself contributes to larger pores), 
but also in the easier exclusion of entangled copolymer from the frozen solvent (due to 
its hydrophobicity), giving rise to larger ice crystals and consequently larger pores 
improving water flux. It is noteworthy that the larger pores formed at -20°C probably 
causes larger fenestrations that helps improve permeability. 
Regarding porosity, it can increase or diminish with freezing temperature, it 
depends on the materials constitutive of monoliths193. Porosity seemed to exert no 
effect on compression modulus, once for almost equal porosities between monoliths 
(Table 3.7.) the compressive moduli varies slightly between them but deeply 
comparing to their counterparts prepared at a higher temperature.  
a Porosity values obtained through Archimedes Principle 
b Value impossible to measure, maybe due  to  crumble of structure.  
*No quantified error due to just one measurement 
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By maintaining casting concentration and playing with freezing temperature 
the structures produced (within the same polymer basis) seems to be, once more, 
different among each other. Comparing C2.9% and C2% maybe the thicker walls of the 
former, again, give the monolith a higher stiffness. The higher water flux is probably 
related to these mechanical properties that avoid structure collapsing with increase on 
tortuosity. Comparing C-G, C/P(50:50) and C/P(33:67) with C2.9% it seems like the 
minor distance between imprisoning chains accentuates PVA and GMA effect through 
higher compression modulus.  
P-G monoliths from Table 3.7. present a lower porosity than those on Table 3.6., 
associated with lower pore size that should have diminished the water flux. Although 
the dry compression modulus reflects more stiffness, when hydrated the real 
properties of the support arose and the compression modulus was not possible to 
measure due to water retention in the support (possible pore collapse). 
Regarding dextran monoliths the mechanical properties seemed to be improved 
by increasing acrylamide amount, and decreasing freezing temperature, maybe 
because with smaller pores the imprisoning copolymer effect is enhanced.  
It is noteworthy that each characterizing parameter studied (swelling, porosity, 
etc.) for each support results from an interplay between, pore size, shape, volume and 
orientation, fenestrations size, interconnectivity and materials used (concentration, 
nature), so a deeper study in prepared monoliths is highly demanded to fully 
understand its behaviour.  
Hereupon it seems that the most promising and suitable monoliths to continue 
the work were A-AAm-G(58:12:30), CP(50:50) and C-G prepared at -20°C, due to their 
attractive flow, mechanical properties and stability. 
 
Due to influence of hydrated state analyses on applicability of monoliths the 
elected supports were subject of another analysis. According to swelling kinetics 
(Figure 3.9.) the rate of water uptake showed little difference between specimens. All 
monoliths swelled up to 80-90% in half a minute reaching some sort of equilibrium. 
These similar values can be explained by the similar porosity and pore size. However 
in case of agarose monolith compressive modulus seemed to exert no effect on water 
flow into the monolith reflecting maybe an independence of water diffusion from 
polymer segments relaxation174. 
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Figure 3.9- Swelling kinetics of A-AAm-G(58:12:30), C-G and C/P(50:50). 
 
 
3.3.3. Magnetic Field Responsive Monoliths 
 
Chemical co-precipitation was the elected method to synthesize the 
superparamagnetic iron oxide nanoparticles (MNPs) due to its cost-effectiveness and 
simplicity. The superparamagnetic nanoparticles synthesized presented, as expected, a 
large hydrodynamic diameter of 655±35 nm, consistent with the literature values86,87. 
The polydispersity value 0.7 is high and so the particles synthesized are not 
homogeneous. Regarding zeta potential (-2.69±0.21V) it evidenced a negative surface 
for the particles at pH5.6 as already noticed86,87.This low value explains the large 
hydrodynamic diameter determined, once the not stabilized bare MNPs tend to 
aggregate and form larger clusters..  
 
Magnetic-field sensitive monolithic cryogels (hybrid monoliths) in which MNPs 
are dispersed and incorporated were developed. These ferro-cryogels combine the 
magnetic properties of particles and the elastic properties of the cryogel. Moreover the 
biocompatibility of MNPs does not compromise the applicability of monoliths in 
question87. The embedding of MNPs onto the monoliths renders them spongier and 
seems to confer them some additional robustness and elasticity (Figure 3.10.).  
Morphologically on a macroscopic level all monoliths are comparable to the non-
magnetic ones in terms of wetting rates and geometrical preservation of shape upon 
complete hydration over 24h.  Some characterizations were performed in order to 
ascertain if native monoliths morphological and mechanical properties are maintained 
or not. Table 3.8. shows that for all specimens the MNPs embedding seems to first 
cause little decrease (24/46 mg/mL) and then a slightly increase (51/67 mg/mL) in 
porosity values. This close values probably reflect the good distribution of the particles, 
forming low aggregates due to stabilization by the polysaccharides. Maybe the 
decreasing value reflects the preference of the particles to remain on surface of pores 
(higher surface area), which when in higher concentrations due to some attraction they 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
W
u
 (
%
) 
Time (min) 
C/P(50:50)
A-Am-G(58:12:30)
C-G
 Development of Monoliths For Viral Particles Purification 
 
71 
 
migrate faster for the interior of struts during crystallization. However MNPs leaching 
in ethanol during porosity measurements can be a possibility, so further studies on the 
matter should be done to exclude this possibility. 
 
 
 
 
Figure 3.10.- Digital pictures from C-G monoliths: dry monolith embedding MNPs (A, on the 
left) and native monolith (A, on the right); hydrated magnetic monolith (B, on the left) and 
native monolith (B, on the right); sequential squeezing of hydrated magnetic monolith (C1-6) 
and native monolith (D1-3). Both recover its original shape after deformation.  
 
 
Once more, due to the high porosity and consequent interconnectivity of the 
monolithic networks, no pressure was necessary to make water flow through the 
support, so measurements were performed at 1atm (25°C). Upon hydration 25mg/mL 
magnetic C/P(50:50) presented a more fragile character than the other supports, and 
maybe enough to cause some pore collapse and consequent tortuosity increase with 
pore closure. This may have led to the immeasurable flux under gravitational force; 
little pressure needed to be applied. In case of C-G and Ag-AAm-G(58:12:30) it seems 
that the MNPs embedding causes an increase in the water flux. An increase that reveals 
itself astonishing for C-G when the MNPs concentration in the casting solution is 
raised (1620±377 L.m-2.h-1). This probably happens once hydrated C-G presents a 
decrease in compressive modulus when MNPs concentration in solution is raised, 
conferring the support enough elasticity to endure such a high water flux. However the 
same is not verified for Ag-AAm-g(58:12:30) maybe due to some pore obstruction 
caused by the MNPs leaching corroborating the porosity value. 
  
B A 
C1 C4 C2 C3 
D3 C5 C6 D1 D2 
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Analysing globally the compressive modulus surprisingly it seems that for 
both dry and hydrated states the increasing of MNPs concentration is followed by a 
decrease in moduli values.  
 
 
Table 3.8. – Morphological and mechanical comparison between non-magnetic and magnetic 
monoliths with MNPs at two different concentrations for each specimen. All data was 
obtained from duplicated measurements (in case of water flux measurements each one of the 
two samples was measured three times). M_C/P(50:50) denotes magnetic C/P(50:50), the same is 
true for the others. 
Monolith 
[MNPs] 
(mg/mL) 
Porositya 
(%) 
Water Flux 
(L.m-2.h-1) 
 
Compressive Modulus 
(kPa) 
Average 
Pore Size 
Diameter 
(µm) Dry Wet 
C/P(50:50) - 94.6±0.3 151±43 1.5±0.3 0.7±0.3 33±9 
M1_C/P(50:50) 25 90.7±0.2 n.a. 0.8±0.6 0.2±0.05 n.a. 
M2_C/P(50:50) 51 93±1 - - - - 
C-G - 93±1  209±18 3.2±0.3 1.9±0.1 111±31 
M1_C-G 25 92.1±0.4  224±32 0.7±0.2 0.3±0.01 154±54 
M2_C-G 51 95±1 1620±377 - 0.09±0.01 - 
Ag-AAm-G(58:12:30) - 95±1 265±44 2.4±0.1 0.7±0.05 34±8 
M1_Ag-AAm-G(58:12:30) 46 92±1 324±1 0.9±0.3 0.4±0.2 54±16 
M2_Ag-AAm-G(58:12:30) 67 92.8±0.5 247±19 - 0.1±0.05 - 
 
 
Apparent density takes into account the whole monolith volume whereas 
true density takes into account only the composites volume. Thence there is a 
discrepancy between these values for all specimens (Table 3.9.).  It was also noticed 
that both apparent and true densities for dry state monoliths are several times lower 
than for hydrated ones. This is explained by the huge water uptake ability of the three 
specimens. 
Dry and hydrated state non-magnetic monoliths have also different apparent 
densities between specimens reflecting the macroscopic observations: C/P(50:50) and 
C-G present similar and slightly shrinked structures contrasting to Ag-AAm-
G(58:12:30), with reflections in their hydrated volume. Thus Ag-AAm-G(58:12:30) 
despite its higher hydrated volume, its superior mass endows it with higher apparent 
density. The same was verified between magnetic monoliths.  
As expected the true densities present higher values (same mass but 
polymers volume instead of whole rod volume). It seems that the water uptake 
capacity is slightly higher for C/P(50:50) and C-G both magnetic/non-magnetic 
monoliths (ratio of hydrated and dry true density) going against the conclusions 
drawn through compressive modulus, where to the stiffer materials less water uptake 
is expected. In case of native monoliths the lower hydrophilic/hydrophobic composites 
a Porosity Measured through Archimedes Method 
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ratio of Ag-AAm-G(58:12:30) possibly explains uptake value. On the other hand the 
presence of particles could have reduced global charge inside the cryo-monolith (due 
to interactions between –NH3+ and –O- of MNPs), and the less charge attracts less water 
molecules into monolith that swells less). Moreover due to MNPs presence probably 
the water binding the surface chains and MNPs finds itself hindered to penetrate walls. 
The H-bonding established between the polysaccharide and the particles could have 
slightly diminished the water necessity for solvation of the molecules. 
As expected, the relative density of dried monoliths was significantly lower 
than the hydrated ones. As in elastomeric cellular solids194, prepared monoliths should 
vary its relative density proportionally to compressive modulus. It is verified only in 
hydrated state, maybe due to volume measurements associated errors. The relative 
density independence from porosity reinforces the independence of compression 
modulus from porosity verified on Table 3.8..  
The high and similar total pore volume explains the high and similar 
porosities of scaffolds, either magnetic or non-magnetic and between specimens. These 
high values, together with high elasticity of modified matrices, can explain the high 
permeabilities. In case of Ag-AAm-G(58:12:30) the total pore volume decreases when it 
is modified. Maybe a thickening of walls accompanied by an enlargement of pores 
explains it.  
 
 
Table 3.9. – Pore volume and density values for magnetic and non-magnetic (native) 
monoliths. All data was obtained from duplicated measurements. M_C/P(50:50) denotes 
magnetic C/P(50:50), the same is true for the others. 
Monolith 
[MNPs] 
(mg/mL) 
Apparent Density 
x103 (g/cm3) 
True Density x10-1 
(g/cm3) 
Relative Density x10-
3 (g/cm3) 
Total Pore Volume 
(cm3/g support) 
Dry Wet Dry Wet Dry Wet Dry Wet 
C/P(50:50) - 87±18 713±110 28±5 668±215 1.48±0.41 10.8±1.9 8±2 1.3±0.2 
M_C/P(50:50) 25 96±6 1015±94 36.2±0.5 801±4 0.96±0.18 8.4±1.3 8±1 0.9±0.1 
C-G - 71±6 782±12 33±4 533±8 0.92±0.02 8.8±1.4 11±1 1.09±0.02 
M_C-G 25 72±11 883±152 37.2±0.9 548±27 0.46±0.01 5.9±1.8 11±2 1.0±0.2 
Ag-AAm-G 
(58:12:30) 
- 78.6±0.5 1084±49 75±5 835±296 0.30±0.07 4.8±0.2 11.38±0.01 0.8±0.1 
M_Ag-AAm-G 
(58:12:30) 
46 100±4 1003±47 91±7 998±40 0.32±0.08 3.0±0.6 8.9±0.5 0.90±0.04 
 
 
To a higher total pore volume is associated a higher stiffness (chitosan-based 
monoliths). This fact could be explained by an increase of pores together with the 
influence of materials (PVA, GMA). 
The swelling ratio in deionized water after 10 minutes was: 8.0±0.4 (Ag-AAm-
G(58:12:30)), 10.8±0.2 (M_Ag-AAm-G(58:12:30)), 17.5±0.5 (C-G), 13.7±1.1 (M_C-G), 
17.7±0.1 (C/P(50:50)) and 18.1±1.4 (M_C/P(50:50)). Despite Ag-AAm-G(58:12:30) pore 
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volume and elasticity it has the least adsorption capacity, probably due to its lower 
hydrophilic/hydrophobic composites ratio. The lower values of C-G magnetic/native in 
comparison with C/P(50:50) magnetic/native should be related to the former minor 
elasticity. Comparing with Figure 3.8., despite the water uptake capacity, Ag-AAm-
G(58:12:30) adsorption rate seems to be the lowest of the three specimens. 
 
The response of magnetic monoliths to four different magnetic-flux densities 
(0.25T, 0.50T, 0.53T and 1.5T) (Figure 3.11.) was tested. Matrix distortion/recovery was 
monitored for 30 minutes. When superparamagnetic materials are posed in a magnetic-
field gradient, forces act on the magnetic entities and due to the strong interactions 
between them and polymers segments, the monolith moves as a sole unit. It was 
verified that shape distortion was relatively fast (varying with specimen and magnetic-
flux density) as well as its vanishing when the external magnetic field was applied and 
removed, respectively (Figure 3.12.).  
 
 
 
Figure 3.11. – Permanent magnets used for field response testing. 
 
 
In fact the measurements performed in the centre (data not shown) or edges 
of the magnet shown a variation: monoliths response was more evident when placed 
near the edges.  
Generally, all monoliths presented a faint response when placed on a 0.25T 
magnet and a clearest one when placed over a 0.53T magnet. The clearest response at 
0.53T magnet over 1.5T is maybe related with the monolith position on the latter 
magnet and its geometry: the two rectangular magnets configuration (attractive or 
repulsive) dictates where the maximum flux density is located195 and in case of 
attractive magnets the maximum is settled near the centre not where the monolith was 
placed; on the other hand the low height-to-length ratio that diminishes  the axial 
component of the flux density rendering flux density quiet non-uniform inside magnet 
(both along its axis and across its length)196 probably enhances the bad monolith 
position; despite the relatively high error bars. 
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Figure 3.12.– Magnetic-field response of Agarose (A-AAm-G (58:12:30)) and chitosan-based 
monoliths (C/P (50:50), C-G) to different magnetic-flux densities: 0.25T, 0.50T, 0.53T and 1.5T. 
The first five points plotted no each graph corresponds to deformation under external 
magnetic-field, the following five corresponds to matrix behaviour after external field removal 
(when reached the initial length no more points were plotted). Data was obtained from 
duplicated measurements.  
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Regarding high response to field C/P(50:50) seems to give the most 
prominent one. However in accordance to macroscopic analysis and results from 
Tables 3.8. and 3.9. the fragile character of magnetic C/P(50:50) was unmasked again. 
Comparing Ag-AAm-G(58:12:30) and C-G, despite the former enhanced response it 
seems that for 0.50T and 0,53T fields 30 minutes were not sufficient for its total 
recovery.  
The stiffer monolith (C-G) seemed the one that faster recovers its initial 
height and the less stiff (C/P(50:50)) is the one that slowly recovers its initial height (not 
recover at all in the 30 minutes) or even collapse.  This reinforces that results are in 
accordance to previous characterizations.  
 
For a deeper and final morphological analysis both magnetic and non-
magnetic monoliths microstructure was analysed by SEM (Figure 3.13.). It was noticed 
that freezing and lyophilization processes produced an open pore microstructure 
provided with a high degree of interconnecting channelling. Non-magnetic monoliths 
exhibited a smooth surface contrasting with the rough coarse-grained like surface 
regarding magnetic ones. For magnetic C-G and Ag-AAm-g(58:12:30) the microscopy 
revealed a uniform distribution of MNPs throughout the matrices with MNPs 
embedded within the walls, confirming pore volume data. This reflects the 
effectiveness in MNPs stabilization by the materials. However the same was not 
verified for magnetic C/P(50:50), in which some clumps or segregations were observed, 
probably as a result of MNPs aggregation as happened elsewhere197. Even the cutting 
stage for analysis can explain the clusters observed (fragile structure destruction). 
Freezing temperature tunes average pore size, originating large pores at -20°C that 
fends MBAAm coils; this together with a probably not so stabilized chitosan/PVA 
physical blend, could probably explain non-uniform MNPs stabilization. A slightly 
decrease on average pore size, as well as loss on pore architecture definition was 
verified for C/P(50:50). This phenomenon should be a result of aggregates formation 
that probably took place before/during freezing, thus compromising pore size 
definition by freezing temperature. Those observations corroborate the mechanical and 
physical information from Tables 3.8. and 3.9..   
In turn an increase on wall thickness for Ag-AAm-g(58:12:30) was not enough 
to reduce water flow, instead a significant increment was verified when MNP were 
embedded; probably due to pore enlargement. This increase in the pore size with gross 
porous morphology maintenance could be an MNPs enhancement effect on ice crystal 
formation. Regarding magnetic C-G pore size and shape heterogeneity increased.  
It seems that fenestrations size is reduced in all supports when MNPs are 
embedded, explaining probably the obtained porosities. 
Comparing non-magnetic supports the smoothest surface belongs to C-G, the 
other supports present some roughness, probably arising from dendritic morphologies 
of ice crystals. 
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Regarding pore architecture on non-magnetic monoliths it was observed that 
the most viscous casting solutions (C-G) presented more oval pores (semi-spherical) in 
contrast to the more uniform pore structures (equiaxed) from C/P(50:50) or Ag-AAm-
g(58:12:30). C-G high compression meduli can be attributed to its thick walls. 
  
 
  
 
  
 
  
Figure 3.13. – SEM micrographs of non-magnetic (A,C,E) and magnetic (B,D,F) chitosan and 
agarose-based monoliths at x300 magnification: Ag-AAm-G(58:12:30) corresponds to A and B; 
C/P(50:50) to C and D; and C-G to E and F. For C-G monoliths a micrograph with lower 
magnification (x100 (left) x150 (right)) is shown. 
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Looking at a different region of native C/P(50:50) monolith (zoomed in Figure 
3.14.) it was noticed the presence of polymeric suspended strings. This can probably be 
explained by freezing kinetics, where entrapment of small fractions of polymer blend 
within ice crystals (in the form of dendrites) can happen. MNPs presence can probably 
favour this phenomenon by innate aggregation tendency, which vanishes with total 
freezing. 
 
 
 
 
Figure 3.14. – SEM micrograph of C/P(50:50) native monolith at a magnification of x500. Notice 
the peculiar pendant polymer strings. 
 
 
3.4. Testing for Non-Specific Binding of Ad5 
 
The promising features of the analysed supports only render them viable if 
non-specific binding between it and Ad5 is negligible. In order to investigate this key 
parameter and validate the monoliths as potential chromatographic supports for 
adenovirus purification, screening tests were performed with the non-functionalized 
prepared supports. With a 1.45x1011 TP/mL virus loading obtained results are 
summarized on Table 3.10.. It is noteworthy that other previously prepared and 
discontinued monolithic supports were also tested. 
Analysing monoliths prepared at -20°C, the results are very interesting once 
magnetic monoliths were the ones presenting the highest recovery values (71-81%), i.e 
only ~20% of viral particles were retained in the network. It is noteworthy that 
screening assays on magnetic monoliths were not conducted in the presence of an 
external magnetic field, even though there performance is still attractive. This superior 
performance could be explained by the determined and observed increase in elasticity 
and average pore size, at least for M_C-G and M_Ag-AAm-G(58:12:30). In case of 
M_C/P(50:50), as expected, a gravimetric flow was not achieved, however applying a 
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slightly pressure with a plunger a good recovery was achieved proving that apparent 
fragile support can handle some pressure without significant collapsing with virus 
entrapment. 
 
 
Table 3.10. – Comparative analysis of different monolithic supports for recovery of 
adenovirus vectors. 
Monolith TFreezing (°C) 
Modification with 
MNPs 
Gravitational 
Flow 
Recovery Yield 
(TPa,%) 
M_C/P(50:50) -20   77±2 
C/P(50:50) -20   57* 
M_C-G -20   81±5 
C-G -20   71* 
M_ Ag-Am-G(58:12:30) -20   71* 
Ag-Am-G(58:12:30) -20   49±1 
C-G -80   84* 
M_C/P(50:50) -80   81±7 
C/P(50:50) -80   79±2 
 
 
 
The viral faction that remained into the support seems to be entrapped by the 
polymeric matrix once previews assays with the supports using an elution buffer 20 
mM Tris 2M NaCl pH8.0 resulted in no additional virus recovery.  
As adenovirus have an average diameter of 60-110 nm114,113,115; commercial 
monolith channels for adenovirus purification varies between 1-5µm5; and the average 
pore size of non-magnetic monoliths prepared at -20°C was between 33±9 µm 
(C/P(50:50)) and 111±3 µm (C-G); the two monoliths prepared at -80°C presenting the 
highest water flux values were also tested (Table 3.7.). Their performance seems to be 
improved even compared to magnetic monoliths produced at -20°C (84% recovery). 
However from all monoliths prepared at -80°C only C-G seems to be promising 
according to Table 3.7. data. 
The overall recovery values were very promising once the support is not 
functionalized, and when a ligand is surface immobilized the access of the virion to the 
monolith wall is deeply reduced due to steric hindrance.   
 
 
3.5. Concluding Remarks 
 
Cryotropic gelation processing of materials followed by lyophilization was the 
strategy adopted, in order to procure a green, relatively robust, mechanically and 
chemically stable monolithic support for viral particles purification. Indeed the 
aTP=Total adenoviral particles 
*No quantified error due to just one measurement 
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methodology employed was successful for the obtainment of supermacroporous 
monoliths.  
In a first approach a whole screening of different combinations of distinct 
materials, and at two different temperatures was attempted. It could be concluded that 
physical blending of polymers and co-polymers together with the MBA proved to be a 
new, greener and efficient way to produce robust, insoluble, stable monoliths with 
attractive gravitational flow. That is, the usage of minimal quantities of a generally 
reported crosslinker molecule not as a crosslinker but instead as an entangling 
imprisoning polymer/co-polymer allows the preparation of a green (cryogelation of 
naturally sourced polymers followed by liophilization) macroporous structure falling 
into monoliths category of chromatographic supports. However to corroborate the 
latter, FTIR analysis should be performed. 
Despite some structures present attractive properties being potentially 
applicable, others fell short of expectations. The conflict between optimizing porosity 
and maximizing mechanical performance was not successful for dextran-based, PVA 
and chitosan alone. However we believe that further optimizations mainly for dextran-
based structures (in terms of its blending with other more rigid polymers, usage of 
lower molecular weight natural sourced polymers, or even change the nature/amount 
of imprisoning polymer) could give rise to a potential and efficient structure for virus 
purification. Molecular weight of synthesized polymers can be tuned through  
initiators concentration plyaing198.  Smaller the chains higher the crystallinity of gel and 
stronger the mechanical properties.  
It could be concluded that blending/copolymerizing chitosan with PVA/GMA, 
respectively, had improved significantly chitosan-based monoliths mechanical 
performance and gravitational flow properties. 
Monoliths processed at higher temperatures presented in general higher 
permeabilities, porosities, and swelling capacity, however lower stiffness character. 
It was found that according to the aims of work, the evaluation of 
morphological, mechanical and physico-chemical properties identified C-G, Ag/AAm-
G(58:12:30), and C/P (50:50), processed at -20ºC, as the most promising supports. 
After election of most promising materials, the magnetic modification was 
executed and the novel materials were characterized. 
It seemed that these new monoliths present different properties from respective 
resemblants like higher flow rates, and lower mechanical properties, thought to be 
caused by cooperative and concerted approximation of particles due to its innate 
attraction. 
Then magnetic and non-magnetic monoliths were tested towards Ad5 to 
ascertain the existent of non-specific binding to supports. 
Magnetic natural polymer-based monoliths seems extraordinarily promising 
towards future virus purification, once not only the surface area is expanded but also 
the non-specific binding values were the lowest ones, with minimum and maximum 
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recoveries of 71% and 81%, respectively. Thus  magnetic C-G was assumed as the 
potentially best candidate for further development of ligand functionalized monoliths.  
However, since MNPs embedding into monoliths induced increased flows, high 
porosity and robustness maintenance, and due to recovery results on monoliths 
processed at -80°C (84%), changes on C-G pore size should be a wise and even more 
promising step towards high throughput adenovirus purification.  
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4.1. Introduction 
 
Therapeutic proteins are nowadays considered the main biopharmaceuticals199, 
and despite many non-proteinaceous biomolecules development, therapeutic proteins 
seems to keep constituting the fastest-growing cantle among all 
pharmaceuticals106,107,199. 
No universal protocol is available to purify recombinant proteins102; however 
affinity chromatography is a high-throughput, selective and efficient technique, that 
results in high protein purity products (>90%) in just one step, from complex mixtures 
of similar molecules200,102,201. An absence of appropriate affinity ligands for a broad 
range of proteins, and the difficult development of a generic protocol for protein 
purification (due to its variety), renders tag fusion to target protein a very appealing 
strategy to achieve the desired capture and purification, with consequent reduction of 
purification steps. Moreover, fusion to a reporter protein seems to ease recombinant 
proteins production201.  
 
GFP (Green Fluorescent Protein) is considered one of the broadest investigated 
and exploited proteins in areas as biochemistry and cell biology202. So taking advantage 
of GFP fusion to proteins to purify the target protein can reveal itself a broad and 
efficient mean of purification.  
GFP was first isolated from the bioluminescent jellyfish Aequorea Victoria203. It is 
a 27-29 kDa protein that comprises 238 amino acid residues folded into a 11 β-sheet 
barrel-like structure, with an α-helix running through the centre and little distorted 
helical portions that stopples the barrel ends providing an unusual protective 
environment for three residues (Ser65, Tyr66, and Gly67) of that α-helix, that form a 
fluorophore204,205. The chromophore results from the covalently rearrangement of 
referred residues during GFP folding process together with oxidation by molecular 
oxygen, in a post-translational intramolecular autocatalytic cyclization reaction204. GFP 
is very stable, being resistant to several proteases, detergents, pH 5.5-12.6 
environments, temperature (Tm=78°C), organic salts, chaotropic agents (8M urea), 
photobleching, or even pressure204,206. Moreover it presents low-toxicity, allows its easy 
detection in cell suspensions avoiding cell lysis, and contributes to minor burden of 
host cells due to its fairly small molecular weight204,206. Once recombinant GFP was 
shown to be expressed in countless species, from bacterial E. coli to animals or plants, 
passing throw fungi, it has been widely used in multiple assays, in many areas of 
science and medicine203,204. This pronounced versatility, together with its large two-
photon absorption, and its harmless character when fused to proteins (no function 
alteration204) renders GFP an appealing candidate in applications such as tag/reporter 
or indicator.  Regarding tagging applications GFP fluorescence mirrors gene 
expression levels or sub-cellular placements, by exposing domains/proteins to which 
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GFP is fused. This allows imaging biochemistry inside cells, visualise chromosome and 
protein dynamics in vivo, etc. As an indicator, GFP can be used to analyze protein-
protein interactions, pH, metal or calcium concentrations by post-translational 
modulation of its fluorescence204,203.  
This renders GFP “one of the most useful tools in modern science and medicine”207, 
that revolutionized our prospects over biological imaging.  
Due to its extensive usage, countless reports on GFP purification methodologies 
arise, comprising: affinity character, hydrophobic interactions, size-exclusion and ion-
exchange chromatography, phase partitioning, organic solvent extraction, and salt and 
metal precipitation, occasionally applied in combination208. Some reported affinity 
systems comprise: 6-his tag fused GFP towards NiII209; anti-GFP antibodies202; and even 
a GFP-binder 16kDa protein derived from a llama heavy chain antibody, binding GFP 
with high affinity and specificity210.   
Immunoaffinity chromatography that requires biological ligands usage such as 
monoclonal antibodies seems to be the most popular strategy102. However, biological 
ligands commonly tend to present high target specificity and binding capacity, 
together with high costs, low stability and life-span102. Conversely the economic 
structural ligands comprise low selectivity or tend to be leached, committing final 
product purity. The stable, re-usable, and robust biomimetic ligands (synthetic), can 
join the best of both worlds: economy and selectivity102,211.  
Recently, a novel biomimetic ligand towards GFP, ligand A4C7, was developed 
by Pina et al.102 and was successfully tested on agarose beads. It can yield similar 
recoveries and purities, and can surpass the limitations of the previously mentioned 
methods.  In another recent work Barroso et al.27 developed novel chitosan-based 
monoliths suitable for antibody purification. This chapter presents the results from the 
combination of ligand A4C7 with referred chitosan-based monoliths, to create affinity 
systems for cost-effective purification of GFP-fused proteins. 
 
 
 
Figure 4.1. – Scheme showing ligand A4C7 coupled to chitosan-based monolith surface (A), and 
structure of GFP (PDB I.D.: 1ema) (B).  
A B 
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4.2. Results and Discussion 
 
4.2.1. GFP Expression and Production 
 
The plasmid containing the gene that encodes for GFP (pET-21c2) was captured 
(transformation) and amplified in NZY5α cells , chemically competent cells suitable for 
high efficiency transformation212. pET-21c expression vector containing an ampicillin 
resistance gene was introduced to the NZY5α E. coli cells that incorporates it making it 
part of  its own genetic material. Then cells were cultivated on LB agar plates with 
antibiotic to denounce the ones that acquired the foreign DNA, as the cells without 
pET-21c lysed. The latter isolation of plasmid DNA for further transformation allowed 
the determination of its final concentration and purity through standard spectroscopic 
analysis (Figure 4.2.).  
 
 
          
Figure 4.2. – pET-21c isolation and purification was successfully achieved as agarose gel 
electrophoresis (0.8%(w/v) agarose, stained after running) can prove (A): marker, 1st elution, 2nd 
elution (lanes 1, 2, 3 from left to right). First and second elutions recovered through 
NZYminiprep kit for DNA purification were quantified and analysed by NanoDrop 
spectrophotometer (B). 
 
 
As expected, the first elution presented the highest pDNA concentration and 
purity.  
                                                            
2 pET-21c is a widely used system developed for the cloning and expression of recombinant 
proteins in E. coli. For the purpose of this work pEt-21c was subcloned by GeneartTM to include 
a GFP encoding gene. However this created vector keeps the same denomination throughout 
this work 
A B 
M 
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The large scale expression of GFP was performed in E.coli BL21(DE3)  
competent host cells, using first eluted DNA. Indeed the target gene initially cloned 
and established in NZY5α cells (non-expression host), was then transformed into 
BL21(DE3) cells (expression host) for further GFP expression. This strategy aims to 
avoid plasmid instability caused by the production of proteins potentially toxic to the 
host cell, being achieved once non-expression host lacks T7 RNA polymerase gene213. 
The large scale production of GFP was accomplished at the optimal conditions 
determined on small scale studies for a tagged GFP protein: induction with 1mM IPTG 
when OD600nm ranged between 0.6-0.8 at 37 °C and 210 rpm102. Induction extension was 
18h. During expression, growth and GFP production were monitored by fluorescence 
and optical density measurements (OD600nm) (Figure 4.3.).  
 
 
   
Figure 4.3. – Monitoring of Cells growth and GFP expression through OD600nm (A) and 
fluorescence intensity measurements (B), respectively. A correlation between phenomena can be 
seen (conversion of nearly all cell’s resources towards GFP gene expression213). 
 
 
In order to qualitatively determine the relative amount of GFP in different time 
periods an SDS-PAGE analysis was performed (Figure 4.4.). However, to directly 
compare the amount of GFP produced at different times after induction, the loaded 
samples at different induction times were normalized to a final optical density of 1.2. 
Comparing GFP band in lane 6 (18h) and the other lanes, the former seems darker, 
thicker and more defined. 
After GFP overproduction, its extraction from intracellular medium required its 
harvesting and mechanical lysing. A subsequent fractionation through two different 
steps of centrifugation took place and allowed cell debris and membrane fragments to 
be cleared. A clarified soluble extract could be obtained. The samples collected during 
fractionation stage were further analysed by SDS-PAGE and fluorescence (Figure 4.5.).  
Once finished fractionation stage GFP content was also evaluated by BCA assay. 
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Figure 4.4. – Time course SDS-PAGE gel (12.5% acrylamide gel stained with Coomassie Blue R-
250). GFP mass production can be visualized. M represents protein marker; PRE corresponds to 
sample collected at tinduction=0; all following lanes matches the GFP profile at different times of 
induction (2h, 4h, 5h and 18h). The band of GFP is expected to be placed at ~29 kDa102,205. The 
loading volume of each sample was normalized to a constant specific optical density value (1.2).  
 
 
Fluorescence values rose intensively when cells were lysed and fractionated, 
probably due to fluorescence unmasking by cell debris removal.  
GFP presence on centrifugation pellet is explained by contamination of wells, 
due to fluorescence results, and knowledge of GFP solubility in PBS102. 
 
 
 
Figure 4.5. – Fluorescence monitoring during induction time and fractionation (A): 0h-18h 
represents the time after induction; Sc corresponds to supernatant obtained after centrifugation; 
Pc to pellet obtained after centrifugation; Su to supernatant obtained from ultracentrifugation; 
Pu to pellet obtained from ultracentrifugation. Cellular fractionation analysis by SDS-PAGE 
was performed (B): M represents protein marker; PRE corresponds to sample collected just 
before induction; POS corresponds to sample collected after 18h induction. 
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 The fluorimetric and BCA assays to quantify the amount of GFP produced over 
the total protein revealed a 10.8% GFP content (1.11±0.42 mg/mL) in total clarified 
soluble crude extract (10.6±3.43 mg/mL) against 13% GFP from a previous work102. 
 
 
4.2.2. Preparation of Affinity Monolith towards GFP Purification 
 
 
Monoliths based on a 50:50 %(w/w) chitosan:PVA blend prepared at -80°C 
(NC), with and without the incorporation of magnetic nanoparticles, have been 
prepared based on Barroso et al.27 work. Both magnetic and native chitosan-based 
monoliths were activated with argon (Ar) plasma treatment in order to subsequently 
add amine free groups at its surface. The amination step was accomplished using 1,6-
diaminohexane, and was crucial as it guarantees the insertion of a spacer-arm. It pulls 
away the ligand from matrix and alleviates steric hindrance, to facilitate an efficient 
binding between protein and ligand. Besides it has already been used in monoliths for 
a ligand comparable in size27. 
 In plasma surface treatment the polymeric monolith is exposed to a low-
temperature, low-pressure glow discharge. A partially ionized gas (free electrons, 
atomic, molecular, ionic, and free-radical species) named plasma is formed as a result 
of a certain gas imprisonment in a vacuum chamber and its subjection to an electric 
field. In turn this new-born highly reactive species interact with monolith surface 
modifying it214,215.  
Generally, plasma treatment is a fast and solvent free approach which allows 
surface modification through the introduction of chemical species, without creating 
any hazardous by-products. The capacity to retain the bulk material properties 
constant while surfaces are modified is crucial to the success of this technique215,27. 
Besides it is known to reduce non-specific protein adsorption216. 
Argon inert gas was chosen once plasmas generated in pure Ar leads to the 
creation of surface free radicals that can be used for cross-linking or grafting 215. Its 
relatively low cost217 and radical survival for several days make its application 
advantageous in comparison to ammonia plasma treatment214.  
Regarding the surface density of amine groups the experimental values 
obtained can be compared to the ones from the literature (Table 4.1.). Despite the 
highest efficiency of non-thermal plasma activation with amination reaction performed 
outside plasma chamber, and considering the high error bar associated with traditional 
epoxy activation route, the results of amination density by non-thermal plasma 
treatment with direct amination inside chamber were fairly satisfactory.  
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Table 4.1. – Comparative analysis on the efficiency of amination through three different 
approaches: traditional preliminary epoxyactivation, non-thermal plasma treatment followed 
by amination out-of-chamber, and non-thermal plasma with direct amination inside chamber. 
MC denoted for magnetic non-functionalized monolith and NC for non-magnetic non-
functionalized monolith. 
Monolith 
Epoxy Activation Followed 
by Amination 
Plasma Activation with 
Amination Reaction Outside 
Chamber 
Plasma Activation with 
Amination Reaction Inside 
Chamber 
 
[NH2] x10 
(µmol/gsupport) 
[NH2] x10 (µmolg/support) [NH2] x10 (µmolg/support) 
MC - - 14±1 
NC 23±7a 175±5a 20.4±0.3 
 
 
The epoxyactivation route comprised the reaction of epichlorohydrin with 
surface free -OH groups. This results in a dependence of the surface amination 
extension on density and availability of OH groups, and thus on method efficiency. 
During plasma treatment there is a creation of countless potentially reactive free 
radicals, beyond those created from polymers functional groups on the monolith 
surface. So the number of amination sites rise, explaining the higher amination yield. In 
case of amination outside chamber the surface activated monolith is plunged into an 
amine solution (1,6-diaminohexane) allowing the contact of the radicals with a great 
amount of amine. However in case of direct amination inside chamber, the 1,6-
diaminohexane is dragged into the chamber to the discharge zone,  by taking it to 
vapour phase. Due to low 1,6-diaminohexane vapour pressure (0.12 mm Hg at 25°C103) 
and boiling point only at 204-205°C103 (work temperature was ≥160°C), dragged amines 
might not have been sufficient to cover all formed radicals. This could have favoured a 
blocking effect by symmetrical 1,6-diaminohexane (both sides can equally  react with 
nearby radicals), rendering amination not so effective as the former. Another 
possibility can be the presence of oxygen in the amine vapour that inhibits the 
reactions217. The power applied could be raised or the time of experiment could be 
extended, however it was verified that there is tendency for monolith degradation. A 
solution could be the improvement of system isolation (allowing O2 privation and a 
rise on temperature), or optimization of operating pressure218. It is noteworthy that 
outside chamber amination (post-plasma irradiation grafting) takes more time (≈24h) 
than inside chamber amination (double plasma treatment) (only 33 minutes).   
 
 
4.2.2.1. Monolith Functionalization and Characterization 
 
Ligand A4C7, an affinity ligand created by Dr. Ana Pina102, and based on a Ugi-
scaffold was synthesized through a Ugi reaction, a multicomponent reaction between 
four distinct compounds: an aldehyde, an amine, an isocyanide and a carboxylic 
a Values obtained by Barroso et. al27 
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acid102,219,220. It is a chemical sustainable reaction, simple, atomically economic, cost-
efficient, and convergent, in which the overall reaction yield trends to be maximized 
with minimal number of steps involved102,221. 
In order to perform the Ugi reaction on the monoliths a preliminary test on 
monolith stability and MNPs leaching (in case of magnetic supports) was performed at 
typical Ugi reaction conditions (48h assay in 100%(v/v) methanol at 60°C, 220 rpm). No 
MNPs leaching was verified and both magnetic and non-magnetic monoliths 
preserved their integrity.  
The synthesis of ligand A4C7 was performed directly onto the solid support 
(step by step) employing NC compatible solvents and a 5x excess of starting materials.  
Chitosan-based monoliths were firstly modified with glutaraldehyde and the 
success of this step was confirmed by the silver mirror test (Figure 4.6.). According to 
the visualized results it can be concluded that aldehyde was successfully attached to 
the solid phase monolith. No mirror was obtained in either of the negative controls but 
a shiny clear sliver mirror was obtained in both magnetic and non-magnetic monoliths 
(ML and NL respectively). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. – Silver mirror test on aldehyde functionalized monoliths: non-magnetic and non-
functionalized monolith (NC, negative control); non-magnetic and functionalized monolith 
(NL); magnetic and functionalized monolith (ML); Glutaraldehyde as positive control (C+); and 
magnetic and non-functionalized monolith (MC, negative control) (from left to right).  
 
 
Then A4C7 synthesis was completed by addition of remaining components to 
the system. As the ligand comprises a polycyclic aromatic hydrocarbon (pyrene), the 
success of the reaction could be confirmed by fluorescence microscopy observations 
(Figure 4.7.). Controls and functionalized samples were visualized (after regeneration) 
through fluorescence microscopy and fluorescence could be observed only on 
monoliths where the four components of the Ugi reaction were present (1 sec 
exposure).  
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To monitor monolith bulk properties before and after ligand attachment, 
several parameters were measured and analysed (Table 4.2.). In case of non-magnetic 
and non-functionalized monolith (NC), the compressive modulus values are 
comparable with those previously reported27 Comparing  both NC and MC (magnetic 
and functionalized monolith), they present similar porosities, however the latter shown 
an increase in water flux, and a minor compression modulus. In case of both magnetic 
(ML) and non-magnetic functionalized monoliths (NL) they present decreased 
porosities when compared with their non-functionalized counterparts. ML and NL also 
present higher water fluxes and higher compressive modulus in dry state. 
 
 
 
 
Figure 4.7. – Pyrene presence at the surface of NL and ML monoliths: non-magnetic monolith 
functionalized with A4C7 (NL) (A,E); non-magnetic and  non-functionalized monolith (NC) 
(B,F), magnetic monolith functionalized with A4C7 (ML) (C,G), magnetic non-functionalized 
monolith (MC) (D,H) (from left to right). Pictures were taken on the fluorescence microscope 
under bright field filter (A,B,C,D) and fluorescence filter (E,F,G,H) at x40 magnification. All 
supports were regenerated before analysis. 
 
 
However in dry state ML and NL seemed more brittle than native counterparts, 
explaining the compressive modulus. It is noteworthy that ligand functionalization 
seems to approximately maintain bulk rigidity/elasticity of both magnetic and non-
magnetic supports, something that does not happen in case of ligand 22/8 based on a 
triazine scaffold27. Average pore size diameter is in accordance to mercury porosimetry 
values for NC (53±5 µm), and MC presents larger pores than the former. 
SEM micrographs, allowed further elucidation of the internal morphology of 
prepared matrices (Figure 4.8.). The large and semi-spherical pores of NC monolith are 
mantained when MNPs are embedded. Approximately uniform distribution of 
macropores into polymer network is visible; however pore size increases, possibly 
explaining the raise in water flux. MNPs on MC surface seems relatively well 
distributed, however a peculiar pattern, resembling the suspended strings of Figure 
3.14., is found on pores surface. That curious pattern observed, together with the whole 
A B 
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pore, resemble the negative of several little rough staked columns222, that when in ice 
form were connected to each other. They look like hanging networks near pores 
surface. Freezing kinetics could be an explanation and MNPs probably enhance the 
phenomenon (see chapter 3). 
 
 
Table 4.2. – Morphological and mechanical properties of functionalized and non-
functionaliized monoliths. All data was obtained from duplicated measurements (in case of 
water flux each one of the two samples was measured three times). 
Monolith Porosity (%) 
Water Flux 
(mL-1h-1) 
Average Pore Size 
Diameter (µm) 
Compression Modulus 
(kPa) 
Dry Wet 
ML 88±1 708±74 n.aa 1.12±0.30 0.65±0.03 
MC 93±1 164±44 76±24 2.02±0.20 0.64±0.01 
NL 89±1 779±36 n.a. a 2.09±0.69 0.97±0.18 
NC 93.2±0.5 85±7 48±13 5.09±1.1 0.75±0.09 
 
 
SEM image reinforces the possibility of ligand coupling onto monolith. Pores 
apparently obstructed had lost its initial shape and rigidity, however flow properties 
were enhanced. The same is valid for ML that seems to present narrower pores, 
probably explaining its lower water flux when compared to NL, i.e. smaller the pores 
lower the water flow due to increase on surface area, however the inclusion of MNP 
create ups-and-downs on the surface contributing even more to the surface area 
increase. 
Magnetite crystals obtained by co-precipitation (diameter 5-20 nm), with high 
surface area and strong surface forces tend to form clusters. A way to counteract this 
trend is stabilizing them by adding surfactants or coating them with polymers223. The 
embedment of particles into the monolith is a way of coating the particles. 
However with destruction of the matrix structure during axial compression, 
particles could not only be pushed against each other but also be exposed. This could 
promote MNPs aggregation alleviating clamps load over the network, and impart 
virtual elasticity to the support explaining compressive modulus of magnetic 
monoliths from this section and chapter 3. 
 
 
a n.a.: Measurement impossible to perform due to technique applied.  
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Figure 4.8. – SEM micrograph of NC monolith with x300 magnification kindly provided by 
Barroso et al.27 (A), MC monolith with x300 magnification (B), NL monolith with x1000 
magnification (C), and ML monolith with several magnifications: x30 (D), x500 (E) and x1000 
(F). 
 
 
Macroscopically, the colour change denounces the microscopic modification of 
monoliths surface. The shape and bulk dimensions are maintained, however a little 
shrinkage is observed with modification progression (Figure 4.9.). 
 
 
 
Figure 4.9. – Visual comparison between stages of monolith surface modification.  C/P(50:50)80 
native just lyophilized monolith (A), after aldehyde functionalization (B), after A4C7 solid-
phase synthesis (C) (from left to right). 
 
 
To monitor the magnetic response towards external magnetic field exposure, 
ML was placed above a 1.5T permanent magnet and its response was monitored for 1h 
B C
  B 
D
  B 
E 
F
 
 D
  D
 
 B 
A
  B 
B
  B 
C
  B 
 Affinity Monoliths for GFP Purification 
 
96 
 
(Figure 4.10.). The monolith shrinkage has to guarantee the maintenance of pores 
micro-architecture, which has major effects on matrix properties and performance.  
The 1.5T magnetic flux seems suitable enough for further screening tests, once 
the objective of field application is to induct little vertical shrinkage, in order to help 
target molecule expulsion during elution step or undesired molecules expulsion during 
regeneration step (column cleaning toward re-usage). 
It was verified that before any surface modification the dry MC presented 
almost negligible response recovering immediately its initial height upon magnetic-
field removal. The deformation was more pronounced in hydrated state, however the 
recovery was fast (~10 min). Upon amination with plasma technology and aldehyde 
coupling, the hydrated C/P (50:50)80 reduced significantly its elasticity. After stability 
test in 100%(v/v) MeOH during 48h, the monolith C/P(50:50)80 presented again a more 
flexible character.  
 
 
 
 
Figure 4.10. – Magnetic-field response of magnetic C/P (50:50)80 monolith at various 
modification stages at its dry (square) and wet states (diamond): without any modification (A); 
after aldehyde functionalization (B); after stability test in 100%(v/v) MeOH during 48h (C); 
C/P(50:50)80 after A4C7 functionalization. First five points plotted no each graph corresponds 
to deformation under external magnetic-field (1.5T), the following five corresponds to matrix 
behaviour after external-field removal (when reached the initial length no more points were 
plotted). Data obtained from duplicated measurements. 
 
This might be related with molecular polarity: when aldehyde is functionalized 
on monolith surface, the carbon chain of amine cannot be properly solvated by water 
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molecules, though when C/P(50:50)80 is soaked in MeOH these molecules are more 
suitable for the 6-carbon chains stabilization conferring additional material flexibility 
upon field response. 
When C/P(50:50)80 is functionalized with A4C7 and thoroughly washed with a 
cocktail of solutions (final solution 20%(v/v) aqueous ethanol) the capacity to field-
response decreases due to the rigidity imposed by A4C7 coupling, balanced with 
ethanol molecules present (EtOH less polar than MeOH or water). 
 
 
4.2.2.2.  Evaluation of Affinity Monoliths for GFP Purification 
 
 
Screening tests with GFP crude extract (GCE) were performed using the best 
elution conditions tested by Dr. Ana Pina102, i.e under alkaline conditions such as 0.1M 
glycine-NaOH pH9 with (E1) and without (E2) 50% ethylene glycol. 
The leaching of ligand A4C7 from the monoliths ML and NL was tested at both 
elution conditions (Figure 4.11.). This was performed because A4C7 and GFP absorb 
and emit fluorescence at equal wavelengths, and because ethylene glycol is known to 
induce perturbations in the GFP fluorescence through ligand leaching, inducing bias 
on the results102.  
It is verified that elution with E1 buffer caused no A4C7 leaching whereas 
elution in the presence of ethyleneglycol (E2) caused negligible ligand leaching 
comparing with the scale of fluorescence  of obtained GFP samples .  
 
 
 
 
Figure 4.11. – Ligand Leaching assays. A4C7 leaching for NL and ML monoliths at 0.1M 
glycine-NaOH pH 9 (E1) and 0.1M glycine-NaOH pH 9, 50%ethylene glycol (E2). 
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Beyond the two elution conditions two binding conditions were also tested in 
GCE screenings. The two binding conditions were: pH~9 and pH 7.4. According to 
Figure 4.12. (A) the low selectivity of A4C7 for binding GFP seems to be confirmed102. 
Moreover the binding percentage was significantly low, once the maximum GFP 
binding was 20%. Curiously both functionalized and non-functionalized monoliths had 
approximately the same values.It seemed that the majority of GFP, together with great 
part of protein, was expelled from the column in the flow-through and washes, for 
both control and functionalized monolith (data not shown).  
By changing the binding conditions to a higher pH it seems that a higher 
amount of GFP bound to the support (Figure 4.12 (B)); however the amount of total 
bound protein also increased and control samples continued to bind almost the same 
as the functionalized ones. In pairs columns ML and NL, MC and NC were expected to 
bind similarly. ML and NL seem to bind same amount of GFP and total protein at each 
pH; however MC seems to differ from NC, binding more GFP at pH7.4. The magnetic 
monoliths surface lacework (Figure 4.8.) can probably increase GFP binding capacity of 
support, a probable meaningless feature when it comes to shrinked monolith at pH9, 
once the same behaviour is not observed.  
Once chitosan pI is 6.3168, it presents little or even zero charge above 6224; and 
GFP pI is ~5206 so either at pH7.4 and pH~9 it presents a negative charge. The ligand is 
neutral at pH7.4102 and at pH9. Once it is known that aromatic rings can act as H-bond 
acceptors (can also establish hydrophobic interactions206), carbonyl and -NH moieties 
from ligand can operate as H-bond acceptor and donor respectively, and due to Figure 
4.11., it seems like the predominant interactions between ligand-GFP and C/P(50:50)80-
GFP are H-bonding. 
 
 
 
Figure 4.12. – Selectivity of ligand A4C7 towards GFP at different pH values: pH7.4 (A) and 
pH9 (B). Results refer to a batch system where the protein is incubated with the support for 15 
minutes. TP denotes for total protein. 
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Although it was previously verified that, at the tested conditions, A4C7 affinity 
ligand was not very selective for binding GFP, it shown considerable potential to 
selectively recover the small protein102. In this work it seems that only the first 
statement was verified. Indeed regarding the elution stage of chromatography, no 
selectivity towards GFP recovery was verified. All bound protein is retained in the 
matrix, no GFP nor any total protein was eluted for both buffers tested. Even 
regeneration step was not successful in expelling proteins from the polymeric network.  
Against expectations the 50%(v/v) ethylene glycol did not result in significant 
additional GFP recovery. As a polarity reducing agent, and consequently a 
hydrophobic interactions disruptor, ethylene glycol binds to hydrophobic sites of 
desired protein reducing hydrophobic interactions between ligand-target pair225. Then 
if GFP binding happens, E2 condition should have eluted more GFP than E1 one.  
The high GFP concentration values verified in washing steps (data not shown) 
corroborate Figure 4.12. charts, in which less binding corresponds to more GFP 
concentrated washed samples. 
 
Preliminary tests were performed in order to ascertain if the presence of an 
external magnetic flux density have any effect on solution flow through column (Table 
4.3.). Results showed a little increase, faced as promising, once no damage is intended 
to be induced in the support during field application. Internal structure damage not 
only alters support morphological and mechanical properties, but also can entrap the 
molecules avoiding its outlet from column. As error bars intersect themselves more 
samples need to be tested in order to confirm these preliminary results.   
As Table 4.3. results were gathered through already tested (screening) columns 
the lower values obtained (compared to Table 4.2.)  seems to corroborate the 
entrapment of protein inside column. However the large error bars, probably due to 
natural polymers-based materials propensity to have batch-to-batch variations, shows 
that more measurements are necessary to corroborate the apparent tendency.  
 
 
Table 4.3. – Flow analysis through ML monolith after different times of exposure. Monolith is 
kept inside magnet during different periods of time. All data was obtained from duplicated 
measurements (in case of water flux each one of the two samples was measured three times). 
Time of Magnetic Field Exposure (min) Water Flux x10 (Lm-2h-1) 
without exposure 41±7 
0 45±8 
10 51±9 
20 53±7 
 
 
 Affinity Monoliths for GFP Purification 
 
100 
 
It is noteworthy to refer that, during screening assays, the swollen monoliths 
filled the chromatographic column tightly with no by-pass of liquid noticed when 
magnet was or not applied. 
Due to minor binding verified during 15 minutes batch system, and in order to 
ascertain if those low values had their probable origin in time of binding established or 
in the ligand itself, screening assays were performed in batch system for 60 minutes 
and in continuum. The studies had proceeded with magnetic monoliths in order to try 
to guarantee protein elution. Elution condition E1 was elected to proceed due to 
ethylene glycol proneness to introduce bias on total protein recovery values. 
As expected the batch system enhances both specific and non-specific protein 
binding (Figure 4.13.). However the results were not encouraging once the control 
monolith continues binding the same as the functionalized one, which is also 
confirmed by SDS-PAGE analysis (Figure 4.14.). 
 
A4C7 Ugi-based ligand synthesis was performed for the first time in a 
monolith, a solid phase distinct from the widely studied agarose beads. To this joins all 
intrinsic solid-phase organic synthesis drawbacks, including the trouble in translating 
the solution-phase environment of workaday organic synthesis to the heterogeneous 
solid-phase dimension, and the chitosan-based monoliths few studies comparing to 
agarose beads.  
 
 
   
Figure 4.13. – Selectivity of A4C7 towards GFP at different times of incubation: 0 minutes or 
continuous system (A), 15 minutes (B) and 60 minutes (C) batch system. Binding condition: 
pH7.4.  
 
 
Solid phase organic synthesis (SPOS) is generally associated with: 
heterogeneous reaction conditions (nonlinear kinetics); irregular distribution and/or 
accessibility of chemical reaction;  and solvation issues226. Due to difficult analytical 
characterization of intermediate by-products and impossible purification from those 
by-products that covalently bind C/P(50:50)80, we are not certain about what has been 
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synthesized at C/P(50:50)80 surface227. Moreover limitations can be associated to the 
polymeric matrix: modest loading capacity, restrict mechanical stability or non-suitable 
reagents infiltration due to hydrophilicity of support.  
Monoliths are extremely advantageous when it comes to macromolecules like 
viruses and cells, and it was shown to be applicable on hIgG purification as well27. 
However hIgG have 150-170 kDa and GFP only 27-29kD and the capacity diminishes 
with decreasing molecular weight. Fouling of monolith by non-specific binding, pore 
obstruction by residual material, or steric hindrance by inadequate ligand synthesis are 
also possibilities. 
High selectivity is mainly required when working with crude feedstocks; 
otherwise the impurities block the available surface for adsorption of the product. So 
having in mind solid-phase synthesis drawbacks, probably the surface-functionalized 
compound does not present the desired selectivity. 
 
 
     
 
 
Figure 4.14. – SDS-PAGE analysis of GFP screening on magnetic functionalized (ML) monoliths: 
Continuum assay (A); 15 minutes batch assay (B); 60 minutes batch assay (C). M corresponds to 
protein marker and lanes 1, 2, 3, 4, 5, 6, 7, 8, 9 denotes for: loading, flow-through, 1st wash, 2nd 
wash and 1st elution for ML and loading, flow-through, 1st wash, 2nd wash and 1st elution for 
MC, respectively.  GFP bands position (~29kDa) is highlighted. The gel was silver stained. 
 
 
B 
C 
GFP GFP 
GFP 
A 
 Affinity Monoliths for GFP Purification 
 
102 
 
The elution performed under external 1.5T magnetic-field was not successful: 
the support retains the proteins. The time of exposure to external magnetic-field, in 
which the monolith was only placed into permanent magnet when elution began, and 
not before elution, precluded any effect. This seems to happen this way once, yet with 
no magnet, the regeneration step presented little outlet of GFP suggesting that the 
chromatographic column should be placed into the magnet sooner, and maybe left 
there for regeneration step (data not shown). 
Moreover the method used for MNPs synthesis, co-precipitation, is sometimes 
characterized by aggregation, poor crystallinity with consequent low saturation 
magnetization values, and early ion oxidation before precipitation, what disturbs the 
physical and chemical properties of MNPs228. This can contribute to a lower response of 
the particles embedded on monoliths. 
It was verified that after screening assay the monolith presented a decreased 
rigidity, probably caused by previous shrinkage. However despite the slower recovery 
verified, the monolith restores its initial height ensuring thus its physical capacity to be 
subjected to another screening assay if necessary (Figure 4.15.).  
 
 
 
Figure 4.15. – Magnetic-field response of ML monolith before and after screening assay.  
 
 
4.4. Concluding Remarks 
 
 
Direct amination of monolith surface inside plasma chamber proved to be a 
green, safe, fast and reliable methodology. However optimization of the system is 
imperative in order of it to display its full potential.  
Monoliths C/P(50:50)80 were surface functionalised to allow in situ synthesis of 
ligand A4C7, which has been previously shown to allow GFP purification in agarose 
chromatographic systems. It was observed that ligand coupling renders the support 
less elastic while increasing the gravitational flow. Monoliths with the incorporation of 
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magnetic particles respond to external magnetic field and shows potential to elute 
faster and help column regeneration. 
These preliminary studies concerning the development of green monoliths with 
affinity towards GFP denounce the necessity to optimize Ugi-based ligand synthesis in 
solid phase monolith platform. 
In future studies it should be performed quantitative and qualitative assays to 
evaluate if there are intermediates formed during SPOS until final product generation. 
An XPS analysis can be a helpful tool, as the most broadly used surface analysis 
technique, involving fine simplicity in usage and data interpretation. Optimization 
regarding total characterization of binding thermodynamics, elution and regeneration 
conditions is also imperative. Competitive elution can be a hypothesis, as well as 
temperature, chelating substances or chaotropic agents.  
As to date, no selective synthetic affinity ligand for GFP and GFP-fused 
proteins purification is available, and monoliths present themselves as suitable tools 
for minor proteins purification, it is crucial to understand what could have failed in the 
case study.  
It is noteworthy that only an affinity monolithic system (CIM IDA-Cu2+) had 
been employed on purification of GFP proteins229. With a capacity of ≈30 mg/mL the 
system lead to a purity of ≈90%. The support itself lacks some advantages that can be 
overcome by natural polymer-based monoliths. 
 
 
 
 
 
 
  
 
104 
 
 
 
 
 
 
 
 
 
 
General Conclusions And Recommendations For Future Work 
 
105 
 
 
5 GENERAL CONCLUSIONS 
AND RECOMMENDATIONS 
FOR FUTURE WORK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General Conclusions And Recommendations For Future Work 
 
106 
 
 
 
107 
 
Environmentally friendly cryotropic gelation combined with freeze-drying 
proved to be a reliable method for processing naturally sourced polymeric 
macroporous structures with biocompatibility, low footprint and high flow-rates 
sparing pressure usage or only requiring negligible pressures. 
A review on the literature concerning chemistry of the compounds (polymers, 
monomers, initiator and catalyst) employed to perform the reactions lead to the 
conclusion that it is very likely that the structures produced comprise a mix of 
interactions. That is, the pre-formed polymer chains interact with each other physically 
by H-bonding, and the monomers AAm, MBAAm and/or GMA polymerize probably 
forming little/medium imprisoning polymerized chains entangling the physically 
interacting pre-formed chains, and holding together the 3D matrix. The temperature 
conditions applied to the system seems to disallow the covalent linkage between those 
monomers and –OH and/or –NH2 groups of the pre-formed polymer chains. However 
this theory must be proved by further looking on the arrangement of molecules 
composing the monolithic matrices, to prove the inexistence of covalent linkages 
between formed and pre-formed chains. A FTIR analysis should be helpful. Anyway 
this probable behaviour between chains seems to be insufficient for the structural 
stability of Dextran-AAm-GMA, and PVA-GMA monoliths. Even though the 
“reticulation” involved in this work seems not to be a conventional one, it would be 
interesting to evaluate the reticulation degree230. The execution of degradability tests 
for the chosen supports with agarase and lysozyme respectively would be also 
interesting. 
Through monoliths characterization it was possible to conclude that their 
properties depend on a whole set of variables: the nature of composites, proportion 
and concentration on casting solution; with implications on porosity, pore distribution, 
size and tortuosity, interconnectivity, fenestration size and distribution, pore 
uniformity and consistency throughout all support.  
The produced monolithic structures were highly permeable, chemically and 
mechanically stable with exception of Dextran-AAm-GMA, PVA-GMA and P100%. 
These structures crumbled easily in solution when mechanically disturbed with a 
tweezers, regardless of pH environment. The increase on P100% crosslinker (maleic 
acid) or its substitution with boronic acid, and the addition of a crosslinker in case of 
the other specimens could be attempted, however as the objective of the work is a 
biodegradable support, maybe it is wiser in a future approach to combine dextran 
polymer with other polymers like chitosan, gelatine or gum Arabic (preferably with 
lower molecular weights). Another possibility could be the execution of a series of 
freeze thaw cycles (to obtain strong physical bonds)144. An increase on mechanical 
properties can also be attempted by playing with initiator pair TEMED/APS 
concentration (concentration increase corresponds to the formation of a more rigid 
structure)198. However, heterogeneous structures can be obtained231. 
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Glass transition temperature measurements of candidate monoliths should be 
interesting once mechanical properties can be adjusted with temperature. 
MNPs embedding and entrapment in the monolithic network is technically 
practicable and straightforward, and seem to induce larger pores formation, increased 
water flux and more pronounced elasticity in the supports. In addition the presence of 
MNPs buried within the polymeric matrix allows support deformation and recover 
cycles helping purification assays. Furthermore the exposed MNPs at the surface help 
to balance the surface area. As different combinations of materials were used for the 
MNPs embedding approach, and the quantities employed were based in previous 
works performed in our lab concerning chitosan/PVA monoliths frozen at -80°C, 
additional studies should be made regarding the limitations on the amount of 
nanoparticles that can be added to prepared materials, due to the polarity 
incompatibility between embedded nanoparticles and polymerization mixture48. TEM 
analysis would also be interesting to confirm if MNPs are either buried or exposed on 
the monolithic surface in a uniform fashion or not77.  
Regarding GFP and Ad5 sizes, and obtained results, maybe a decrease on 
freezing temperature is a wise step on future developments. Hypercrosslinking could 
also be a smart strategy in case of GFP purification. It is a newly developed approach 
proven to enhance the efficacy of polymeric monoliths for small-molecules separation, 
that comprises a post-preparation modification allowing the maintenance of original 
pores and porosity with the preparation of an additional extensive network of smaller 
pores, and consequent substantial boost on surface area232,51. However, to guarantee the 
preparation of a biodegradable material with minimal footprint, biodegradability tests 
should be performed. Thus an even more attractive approach could be the preparation 
of a double-continuous macroporous network via sequential freezing–thawing, that 
guarantees good mechanical properties233. 
Stability tests over CG frozen at -80ºC, and C/P(50:50)80 with and without A4C7 
should be executed. Chops of each specimen should be submerged for 12h into 
solutions normally used during cleaning-in-place procedures. 
It is important in future developments to evaluate quantitatively the 
conservation of virus infectivity. 
Optimizations regarding the synthesis of the synthetic ligand on monolith 
platform are imperative in order to create an ideal stationary phase for GFP 
purification, competitive towards the well-established agarose beads. If this stage is 
achieved with success it would be interesting to perform the scale-up screening 
between the ligand and GFP in an automated system. 
In order to allow future processing of larger volumes of analytes in this type of 
attractive devices, it would be interesting to perform scale-up studies on natural 
polymers-based monoliths. However according to research realized and results 
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obtained only lab scale disposable supports should be attainable (industrial scale seems 
unlikely due to mechanical properties of natural polymers-based supports).  
Supercritical fluid (CO2) technology should be an alternative and promising 
platform for natural monolith preparation, due to homogeneous pore tuning (narrow 
pore size distribution) with expulsion of unreacted species, and attractive energetic 
costs79. 
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